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Abstract
Human adipose stem cells (hASCs) provide a research tool for regenerative medicine in
various capacities. There are major research needs for new therapies for bone-related
diseases such as osteoporosis, osteomyelitis, and severe trauma. Human ASCs can selfrenew for extended durations outside of the body and provide an ideal platform to
study therapeutics for the formation of bone-specific modalities or wound healing
applications.
Combining hASCs with nanomaterials is a growing area of research that requires
additional studies. Halloysites (HNTs) are hollow aluminosilicate nanotubes with an
exterior negative charge and a positively charged lumen. HNTs have demonstrated
biocompatibility in cell and animal-based studies, with additional capabilities for vacuum
loading of drugs and coating metal ions such as silver, zinc, strontium, and copper
(mHNTs). Metal ions provide synergistic antimicrobial effects on prokaryotes, allowing
healthy cells to form in infection risk areas. These unique properties allow a varying of
methods to be developed in cell-based therapeutics at the tissue level.
The primary focus of my research is to investigate the therapeutic potential of metalized
HNTs with a linked tripeptide known as GHK (glycyl-L-histidyl-L-lysine). GHK is known to
be essential in the wound healing process. Ultimately, studying these interactions will
lead to better bandages to be hemostatic, alleviate pain and inflammation, and costeffectively possess antimicrobial features. Bone and wound analysis studies were
conducted on hASCs after the incorporation of such nanoparticles. Results introducing
GHK with metalized HNTs showed increased proliferation of hASCs, collagen production,
and an increase in the genes ki67 and runx2, a proliferation and bone marker,
respectively. Strontium-coated HNTs increased osteochondral differentiation after
analysis by phase-contrast imaging, gene expression, and unique morphological changes
of hASCs exhibiting trabecular-like bone formations in culture.
Copper-coated HNTs coupled with GHK increased wound closure after artificial wound
analysis, further validating gene expression and proliferation studies. Human ASCs were
additionally encapsulated in alginate hydrogels with GHK and mHNTs that increased cell
viability and collagen production, leading to differentiated fibroblast clusters within the
hydrogel constructs. Given these results, expanding the use of mHNTs with GHK in
animal wound healing studies can profoundly impact wound healing if incorporated into
FDA-approved materials.
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CHAPTER 1
INTRODUCTION AND BACKGROUND

1.1 Regenerative Medicine
The ongoing need to standardize tissue regeneration capabilities is a pressing
issue. According to Col. Brian Eastridge of the US Army Institute for Surgical Research,
90% of preventable deaths on the battlefield occur due to “bleed-outs” where the
wounded service member dies from blood loss before reaching a medical facility1.
Preventing deaths of this nature is due in part to limited supplies in high-risk areas, as
well as the increased danger for transporting individuals under extreme duress. The
introduction of advanced treatments outside of the clinic for extensive vascular damage
in combat areas or for people without proper medical access is an area of interest that
can be improved considerably. In developing countries, motor vehicle accidents, street
crimes, improvised explosive devices, and industrial accidents are common ways
civilians experience vascular injuries of the extremities. In Pakistan specifically, only 41%
of 328 documented patients were doctors able to save their arm or leg; 5.48% lost their
life2. The loss of limb for citizens in Pakistan was due to the prolonged absence of eight
hours or more from healthcare facilities, leading to the deterioration of significant
vessels or arterials in these advanced trauma areas. Evidence suggests that superior

1

2

military and civilian medical treatments are needed to stop otherwise preventable
deaths from occurring due to excessive blood loss, pathogen exposure, and prevention
of limb loss before transport to a medical facility.

1.2 Human Adipose Stem cells for Tissue Regeneration
Human adipose stem cells (hASCs) provide a research tool for regenerative
medicine to be utilized in various capacities. There is a critical research need for
additional therapies for bone-related diseases such as osteoporosis, osteomyelitis, and
severe trauma areas that can employ the ability of hASCs to differentiate into multiple
tissue types such as bone, cartilage, and muscle3. Human ASCs can self-renew for
extended durations outside of the body and provide an ideal cell source to study
therapeutics for bone-specific treatment modalities and other connective tissue
disorders. Understanding the dynamic nature of hASCs for bone tissue formation
provides a platform for future clinicians to take advantage of hASCs for many connective
tissue pathologies.
Human ASCs are abundant and easily accessible in adipose tissue, providing less
invasive procedures than other mesenchymal stem cell populations, such as bone
marrow stem cells (BMSCs). Not only this, much larger yields of hASCs can be isolated
and collected from fat tissue at 250,000 cells per gram, compared to only 50,000 cells
per gram of aspirated bone marrow4,5,6. Adipose tissue is often disposed of from surgical
procedures too, and the fat tissue remains viable for up to 24 hours at room
temperature, making it an ideal cell source. Moreover, adipose tissue can easily be
acquired through needle biopsy and liposuction procedures. Conventional surface
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markers for defining hASCs through flow cytometry are CD73, CD90, CD105 positive and
CD14, CD19, CD34, CD45 negative7. The increased cell number per gram and the
accessibility of fat tissue are two key components that support hASCs application in
tissue regeneration studies over BMSCs.
Additionally, hASCs remain viable in cell culture for extended periods in a variety
of cellular mediums. The ability of hASCs to be passaged significantly more times than
other stem cell sources without fear of genetic malformations is another critical
characteristic they possess8,9,10. Moreover, when cryopreserved, hASCs are well
maintained, allowing researchers to study epigenetic factors including force, elasticity,
and genome editing4. All of these reasons make hASCs the ideal cellular source for tissue
regeneration studies long-term.
As with other stem cell populations, hASCs are vulnerable to environmental
pressures acting on them, such as temperature, pressure, microenvironment, and
bioactive components11. Thus, understanding how hASCs respond to extracellular cues
experienced in the body is crucial for optimizing their use in clinical settings. However,
mimicking how hASCs respond in the body remains increasingly difficult as hASCs
respond to several environmental cues such as sheer pressure/force, biochemical, and
substrate adhesion. Directed differentiation and self-renewal processes experienced in
the body are difficult to mimic simultaneously and achieve in lab-based
experiements12,13. However, if we can discover the roles environmental forces and
mechanisms of biochemical cues' play in differentiation and proliferation, hASCs remain
an ideal candidate for degenerative bone conditions and areas of extreme trauma. For
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instance, osteoporosis affects postmenopausal women, where bones weaken
significantly over time. In these cases, bone weakening gives rise to broken bones,
fractures, and complications due to infection experienced at an older age 14.
Human ASCs can be utilized and implanted in patients to stimulate formation of
new, healthy bone tissue. There are growth factors secreted by hASCs, such as FGF-2
and VEGF, that stimulate angiogenesis through ligand stimulation of enzyme-linked
receptor tyrosine kinases (RTK) and directly relate to the formation of healthy bone
tissue or other cell lineages2,15. FGF-2 and VEGF secreted factors also direct stem cell
movement, acting as signaling molecules for immune cells in the wound healing process.
Considering the exosome profile existing in the extracellular matrix is essential to note
in future studies for characterizing how hASCs or other immune cells in tissue-damaged
areas respond by the introduction of biochemical nanomaterials. Understanding how
the environment impacts hASCs and their ability to aid in tissue repair will alleviate
bone-related pathologies or advance wound healing applications and so needs further
study.

1.3 Biomaterials for Tissue Regeneration
Biomaterials have a variety of applications in medicine, including drug delivery,
pharmacokinetics, and tissue engineering. Biomaterials are especially useful in biological
systems because they do not provoke an immune response and are biodegradable.
Combining a cell source with a biomaterial tells a researcher how cells adhere,
proliferate, and what genes are influenced by external cues. In particular, biomaterials'
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ability to be functionalized to mimic mechanical strength, degradation rate, and cellular
adhesion of natural tissues provides a helpful scaffold for differentiation studies 10,16,17.
While biomaterials can be diverse, they can provide a 3D scaffold that better mimics the
ECM of the body than traditional culture dishes18. Culture dishes grow cells in a 2D
environment that do not accurately represent physiological conditions. The 3D scaffold
of biomaterials allows researchers to better characterize how cells respond to specified
environmental cues.

Figure 1-1. FE-SEM Image of unmodified HNTs (Left), showing the structure of HNT
(center) and a schematic Illustration of the chemical structure of HNTs (Right) 19.
Combinational methods of hASCs with nanomaterials are a growing area of
research needing additional studies. Halloysites (HNTs) are hollow alumina silicate
nanotubes with an exterior negative charge and lumen positively charged20. These
nanoparticles range between 100-900 nanometers, while the lumen spans roughly 20
nanometers across. Figure 1-1 illustrates the chemical nature of HNTs and their
cylindrical structure by SEM imaging. HNTs have demonstrated biocompatibility in cell
and animal-based studies, with additional capabilities for vacuum loading of drugs and
coating metal ions such as silver, zinc, strontium, and copper (mHNTs)21,22,23. Vacuum
loading drugs into mHNTs provide a significant increase to synergistic antimicrobial
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effects on prokaryotes, allowing healthy cell growth in infection risk areas 23,24,25. Figure
1-2 demonstrates an HNT-copper complex combined with GHK, along with additional
capabilities of vacuum loaded drugs. Furthermore, with antimicrobial properties
established, the interactions of nanomaterials with cellular machinery have vast
capabilities for promoting healthy tissue formation. The increased surface area to
volume ratio at the nanoscale exponentially grows, drastically increasing cellular
interactions to cell surface receptors. In addition, the antimicrobial attributes of mHNTs
and their biocompatibility provide unique properties for varying methods to be
developed in cell-based therapeutics at the tissue level. First, however, various studies
must be performed to understand how genes and proteins interact in the tissue
formation process with mHNTs. Studying these effects at the molecular level will
increase the therapeutic potential for patients.

Figure 1-2. Graphic Illustration showing Cu deposition on the HNT surface and
attachment of the GHK peptide19.
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Though many different compounds and scaffolds are currently being tested,
hydrogels incorporated with crosslinking polymers, or other nanomaterials, are useful to
consider for supportive cellular scaffolds. Polyacrylic acid (PAA), polyethylene oxide
(PEO), and polyethylene glycol (PEG) are commonly used synthetic polymers. At the
same time, fibrin, collagen, alginate, and agarose are natural polymers useful for the
creating this support system16,26,27. Hydrogels designed for tissue engineering
applications absorb water, remain highly hydrophilic, and are structurally similar to the
ECM28. Thus, the surface of hydrogels can be manipulated while still providing a solid
network for cellular attachment or to encapsulate cells for 3D culture studies 29.
Hydrogels also promote gas exchange, prevent nutrient depletion, and readily allow for
the diffusion of macromolecules30.
However, it remains uncertain as to how the insertion of grooves, depressions,
or notches on hydrogels' surface influences cell fate. Furthermore, how other small,
naturally occurring biological molecules modulate differentiation has been observed
through nanosilicates attached to hydrogels facilitating osteogenesis without the need
for bone induction media. The bone induction properties of nanosilicates have led to an
intriguing observation regarding how important external cues are in the osteogenesis of
hASCs31. Additional studies have used nanofibrous mats of chitosan in combination with
cyclodextrin hydrogels for wound healing applications and hemostatic potential, leading
to increased absorbable capabilities32. However, regardless of the materials used within
hydrogel constructs, the varied surface of hydrogels has yet to be optimized, and how it
impacts cellular attachment, self-renewal, or differentiation.
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Elasticity, or rigidity, of biomaterials, is another critical component to consider
when designing a valuable biomaterial for directed differentiation. Each tissue type has
a corresponding elasticity measured in Pascals (Pa) or kilopascals (kPA). For example,
bone tissue is much more rigid. It produces a higher value for elasticity in the range of
40-50 kPA compared to fat and neural tissue corresponding to values under 10 kPa
(Figure 1-3).

Figure 1-3. Elasticities of different cell types, synthetic polymers, and a natural
polymer26,33.
This biomechanical component of tissue is helpful to analyze as studies suggest
that matching the hydrogel elasticity with the elasticity of the desired tissue type greatly
influences differentiation and self-renewal processes34,35. Human cells grown on
hydrogels closely related to its elastic modulus displayed a significant rise of engrafted
cells and lineage-specific markers compared to a standard cell culture dish35. Utilizing
biomaterials will identify the importance of the elastic modulus for influencing stem cell
fate.
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1.4 Wound Healing Fundamentals
The wound healing process is a complex process due to inflammatory markers,
immune cells, chemotaxis, and supporting cellular growth. The healing cascade relies
initially on inflammatory processes to recruit immune cells and stop blood flow through
hemostatic interactions36. Hemorrhage is a leading cause of traumatic injures seen
throughout the world, leading to a total cost of 671 billion within the United States as of
201332. Other complications aside from hemorrhage can occur, and preventing sepsis
and promoting cellular growth is essential before a wound can adequately heal.
Moreover, while typically associated with clotting, aggregation and activation of
platelets promote deposition of extracellular matrix-like transforming growth factor β,
platelet-derived growth factor, fibroblast growth factor, and vascular endothelial growth
factor37. The secretion of growth factors is essential for the wound repair process to
recruit immune cells, mesenchymal stem cells, fibroblasts and stimulate cell
differentiation38,39.
However, the process and timing of subsequent factors are poorly understood,
and mechanisms to understand or speed up the process are essential for chronic and
advanced wound trauma. The wound healing process occurs in four stages that drive
healthy tissue formation over time, including hemostasis, inflammation, proliferation,
and remodeling. Hemostasis occurs in primary and secondary phases. Primary
hemostasis is the initial response in open wound systems to restrict blood loss and
bleed outs. However, the wound healing process is slow activating, so the transcriptionindependent pathway is essential in the first few minutes following injury. Calcium ion
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waves build along the wound edge, propagating toward the center of the wound. The
damaged cells in the area immediately release chemokines for the stimulation of
immune cells by G-coupled receptors39.
The primary hemostatic response is divided into four additional phases:
vasoconstriction, platelet adhesion, platelet activation, and platelet aggregation.
Vasoconstriction and vasospasms occur instantaneously, triggering an initial response
whenever there is significant vessel injury. Vasospasm of the blood vessels induces
vasoconstriction, and in turn, mediates the release of a potent vasoconstrictor known as
endothelin-1, which is secreted by damaged endothelium. In addition, the damaged
endothelium releases several other factors in the hemostatic process, such as
Willebrand factor (vWF) and inflammatory mediators, along with the TF-FVIIa complex,
which acts as a blood coagulant activating an important receptor known as tissue factor
(TF)40. The secreted factors by the damaged endothelium start mechanistic action of
primary hemostasis, leading to platelet adhesion, activation, and aggregation.
Platelet adhesion is the process by which platelets attach to the exposed
subendothelial tissue to form a platelet plug with each other through a tightly packed
integrin network linking other platelets in the area39. Platelets are secreted by
megakaryocytes residing in bone marrow, and after secretion, platelets traverse
through vascular sinuses of marrow to enter the bloodstream41. As platelets begin to
adhere to damaged tissue sites, additional platelet activation is mediated through Gprotein coupled receptors (GPCRs) on the platelet’s surface via thrombin by two
mechanisms. First, thrombin directly activates platelets via proteolytic cleavage by

11

binding the protease-activated receptor. Second, thrombin additionally activates
platelet granule release, including serotonin, platelet-activating factor, and Adenosine
Diphosphate (ADP)42. ADP is an essential physiological mediator that is specifically
stored within platelets and only released upon vascular injury. When ADP is released, it
binds to two important GPCRs known as P2Y1 and P2Y12 along the platelet
membranes43. P2Y1 induces the pseudopod shape change and aids in platelet response
aggregation. Mice deficient in P2Y1 and P2Y12 exhibit longer bleed times as well as
impaired aggregation of platelets at wound sites44. The platelet aggregates formed in
the system are composed of type III collagen, fibrin, and other glycoproteins to
stimulate the release of additional cytokines, promoting angiogenesis. Ultimately,
primary hemostasis allows the culmination of a weak platelet plug to temporarily
protect from hemorrhage until further stabilization of fibrinogen to fibrin via thrombin
occurs.

1.5 Tripeptides for Wound Healing Applications
Incorporating small molecules into an open wound system can aid in recovery,
both for suppressing pain management and speed of wound recovery 45. GHK (glycyl-Lhistidyl-L-lysine) is a naturally occurring tripeptide found in all mammals and a
significant component of type 1 and many other collagens. GHK is released into
damaged tissues after hydrolysis of collagen by collagenases or actively secreted by
fibroblasts. It is theorized to be a feedback signal for fibroblast activation and synthesis
of a reparative extracellular matrix46. Furthermore, over time, circulating levels of GHK
in the bloodstream drop from 200 ng/mL to 80 ng/mL in elderly patients, causing

12

increased problems related to wound healing, cartilage degradation, and wrinkle
formation47,48. GHK is known to have many physiological properties and interact with
genes and proteins involved in skin repair, inflammation, pain, stress, and anxiety45. For
example, transforming Growth Factor Pathway-Beta (TGF-B) and Integrin-Beta 1
pathways were stimulated by injections of GHK-Cu in mouse and rat studies that
reduced aggression or pain, along with improved healing of ischemic wounds45,47. GHKCu was also found to stimulate basal epidermal cells, markedly increasing integrin
expression and p63 expression47. Furthermore, because GHK is a potent chelator, it
binds with high affinity to metal ions such as copper, zinc, or silver through covalent
bonding of free nitrogen groups within the crystal structure of the GHK molecule. Thus,
the metal ions act as transport vesicles to avoid protease activity and aid in the tissue
repair system.
Incorporating GHK with biomaterials is another area to explore. For example,
GHK-Cu complexes in 3D extracellular cryogels accelerated cytokine secretion profiles of
VEGF and members of the Interleukin family for immune homing of human umbilical
vein endothelial cells49. The rise in growth factor secretion and immune homing of GHKCu in cryogels suggests the importance of tripeptides, particularly GHK, in the healing
process. The secretion profiles also suggest that tripeptides could increase wound site
recovery in chronic wound patients or everyday scrapes and burns.
Although GHK appears to be an ideal molecule to use in wound repair, a
significant challenge is to prevent degradation of GHK after incorporation into an open
wound. GHK can further be functionalized with fatty acids, such as stearic acid and
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palmitic acid, that increase its absorption capabilities and prevents degradation of the
tripeptide by protease activity in open wounds47,48. Both stearic and palmitic acid are
among the most common saturated fatty acids consumed in the western diet and could
aid in preventing GHK degradation, thus promoting tissue regeneration50. Palmitic acid
conjugated peptides increase cell permeability while stabilizing peptide delivery to cells.
Modifying peptides with fatty acids can substantially improve their pharmacokinetics,
increasing the affinity of binding to MHC class II and T-cell receptors. For example,
Liraglutide, a peptide drug for treating type 2 diabetes, has a fatty acid attached,
extending the half-life by 11–15 hours, and drug delivery methods with palmitic acidconjugated exendin-4 markedly prolonged circulation of the amino acid complex in
diabetic murine studies51. The stearic acid-modified peptide is resistant to degradation
mediated by thrombin and trypsin, significantly increasing the half-life and
anticoagulant activity52. Peptides conjugated with fatty acid have the potential to
prolong the half-life in the circulation, increase cell penetration, or impact antibacterial
activity. Advanced nanoparticle delivery and layer-by-layer assembly are major research
areas and need additional studies to enhance wound healing processes.

1.6 Synthesizing Tripeptides
Synthesis of peptide chains has been around for several decades, with
advancements directed towards developing therapeutic potential in cell-based systems.
The research need for producing particular proteins or amino acid chains is highly
relevant to studying metabolic functions, pharmacokinetic properties, and tissue
engineering approaches51,53. There are two common ways to form amino acids
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depending on the insoluble nature of the protecting group and the direction of the
synthesis. Solid-phase synthesis uses an insoluble protecting resin, while solution-phase
synthesis uses a soluble protecting resin51. Protecting groups are essential during the
formation process for side chains not to be developed, markedly decreasing purity
levels. Tertbutyloxycarbonyl (Boc)/benzyl (Bzl) strategy and 9-fuorenylmethoxycarbonyl
(Fmoc)/tert-butyl (t-Bu) strategy are the two most common approaches for the
development of peptide chains. The latter, Fmoc, is the ideal strategy for the solidphase peptide synthesis due to the nature of Boc as a protecting compound. Boc often
produces alterations to peptide bonding or side chains after repetitive treatment of
trifluoracetic acid to remove Boc as the protecting group during peptide synthesis, so
the desired choice for solid-phase synthesis with high purity levels is generally Fmoc54.
The peptides can further be built in a layer-by-layer addition through lipidation
methods to improve receptor binding, half-life in circulation, plasma stability in open
wounds, and physiochemical properties55,56. The presence of the fatty acid of varying
links can have large changes in cellular interactions and ultimately the interactions of
genes and proteins within the cell. Palmitoyl esterification of serine or cysteine can
easily be accomplished in trifluoroacetic acid (TFA) solvent for conjugating palmitoyl
group to the peptide chain57. Lipidation methods are attractive strategies for peptides,
proteins, and other small molecules for an enhanced effect in cellular response
pathways.

CHAPTER 2
WOUND HEALING, BONE REPAIR, AND REGENERATION

2.1 Improving Current Healing Capabilities
Deploying a nanotechnology-enabled, multi-functional hemostatic bandage
made from FDA-approved materials and fabricated with additive manufacturing
techniques can drastically improve how we repair wounds from the onset. The use of
tripeptides, like GHK, can potentially impact lives while increasing our knowledge of the
nanomaterial influence on hASCs. Figure 2-1 illustrates how FDA approved materials can
be combined with our biologically active nanoparticle combined with GHK and CuHNTs.
The proposed design is aimed to be hemostatic, alleviate infection, promote tissue
growth, and ease pain and inflammation on skin surfaces. The clinical use of hASCs is an
area of research with potential therapeutic use for various pathologies related to
connective tissue, making it an ideal model to study cellular interactions for the
formation of dermal layers. However, more research needs to be performed to optimize
the clinical potential of bioactive based nanomaterials and directed differentiation of
hASCs for wound trauma. Therefore, understanding how nanomaterials combined with
biological molecules dictate gene expression and influence cell fate are essential factors
for considering tissue engineering models associated with hASCs.
15
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Figure 2-1. A.) A hemostatic bandage incorporated with metalized halloysites and GHK
tripeptides for wound healing applications. The bandage lines the dermal surface in
open wounds, and multiple layers can be created to enhance hemostasis, pathogen
resistance, and promote tissue formation. B.) Proposed GHK-Cu-HNT complex to
incorporate into blow-spun or electro-spun fibers. C.) Blow-spun fibers created and
analyzed by SEM (right) and a prototype bandage constructed (left).
Current bandage components do not incorporate advanced nanocomposite
therapies for stimulation of healthy cell growth, infection control, or tissue
regeneration. Skin grafts are generally used for large scale scrapes or burns58. The
United States government currently employs the “QuickClot” bandage to rapidly
promote hemostasis during battlefield-induced injuries. The components of QuickClot
comprise nanomaterials similar in nature to halloysites, known as kaolin, for enhanced
coagulant properties and stimulation of platelets in open wound systems59,60,61,62. While
the kaolin improves bandage materials comprised in gauze, the materials do not provide
synergistic activities for type I and type III collagen formation or antimicrobial
properties. Deploying bandages in countries without proper medical access or for
warfighters in isolated combat areas remains of interest to prevent septic conditions,
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ultimately save lives in the process. In addition, the wound repair process in the elderly
population slows in epidermal areas, infection rates increase, and complications arise in
diabetic wounds63. My studies will incorporate advancements in current bandage
components to prevent infection, alleviate pain and inflammation, and speed recovery
time. Using hASCs, combined with metalized halloysites and tripeptides, will provide
needed and novel bandage capabilities that provide insight into stimulating trauma
areas in many different populations.
My research aims to fill gaps associated with nanocomposites' biological
relevance for wound healing applications while better understanding the nature of stem
cells and mHNTs. Gene expression analysis, wound healing assays, and
immunofluorescent techniques will be used to identify the cellular effects of our
nanocomposites on hASCs. Understanding and optimizing conditions to differentiate
hASCs could provide an ideal cell population to generate different tissues for patients
suffering from genetic abnormalities, severe trauma, deficiencies, or bone decay. The
proposed research on incorporating tripeptides with metalized halloysites will offer new
wound healing applications after additional studies on animals and humans. Future
research on animals and humans must identify how our functional components can
substantially increase the current bandage capabilities. Our specialized nanoparticles
can easily be incorporated into FDA-approved materials like PLA, chitosan, or cotton
indicated in Figure 2-2. With this technology and additional studies, we are confident
that improving current bandages is possible in the near future.
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Figure 2-2. A.) The proposed bandage solution would be used with FDA approved
materials, metalized HNTs, tripeptides, and drastically improve upon leading
competitors. B.) Chitosan and PLA that can be combined with metalized HNTs in blowspinning methods. C.) PLA printed textiles can be infused with metalized HNTs, or drugs,
and they can provide structural support in tissue damaged areas.
2.2 Bone Formation Processes
The complexities of the bone formation process extend through multiple
mechanistic processes from secreted polypeptides in conical signaling pathways within
the transforming growth factor-beta family or bone morphogenetic pathways64,65.
Furthermore, the similarities between bone and wound healing run parallel because
coagulation and inflammatory phases occur similar to those seen in disrupted skin,
requiring identical molecules associated in these pathways with frequent crosstalk in
trauma-induced areas given the similar regions and tissue types.
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When bone tissue is damaged, a fracture hematoma is replaced by a soft or
fibrous callous as BMSCs are stimulated to form preosteoblasts. Intramembranous
ossification occurs on the border of the fracture site where signaling molecules BMP-2
and RANKL stimulate osteoblast formation65. After initial soft tissues are formed, hard
callus formation follows in 3 to 4 months, giving way for possible injuries to occur or
infection to grow if the union of the fracture is not met66. If the fracture union is
established, the endochondral ossification establishes a bony bridge to stabilize the
fracture and prevent micromotion centrally. Hard callus formation is followed by bony
remodeling through osteoclast activity stimulated by ion exchange of strontium to
differentiate MSCs into osteogenic lineages67, wherein woven bone is replaced by
lamellar bone, similar to the process of exchanging the web of type III collagen for type I
collagen in the skin.
The dynamic process of bone formation requires several steps to take place over
many months in severe bone injuries, often leading to non-union of fracture sites. In
non-union fractures, surgical intervention with autogenous bone from the iliac crest
represents the “gold standard.” Other methods such as low-intensity pulsed ultrasounds,
titanium rods/screws implants, and extracorporeal shockwave therapy exist as well 66.
However, complications of additional surgeries, infection, pain, scarring, and daily trips
to therapy clinics provide problematic scenarios.
There are 3 primary cell types that influence the environmental landscape for
bone formation. BMSC-derived osteoblasts along the basolateral surface interact with
the bone mineralization process, further directing downstream cell differentiation
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processes. Osteoid, the first matrix produced, is comprised mainly of collagen and
calcium phosphate68. Through alkaline phosphatase (ALP) activity on the osteoblast
surface, hydrolyzed hydroxyapatite crystals of the non-mineralized bone matrix fuse to
mineralize the osteoid, forming the bone matrix. Figure 2-3 highlights the integrated
ALP action taking place along the surface of an osteoblast to form healthy bone tissue
with hydroxyapatite crystals in an acidic environment. While ALP exists in several other
tissues in different isoforms, it is imperative in early bone formation processes. Runx2 is
another bone marker directly involved early in determining an osteoblast’s functional
characteristics. It acts as a transcription factor that stimulates downstream targets such
as fibroblast growth factor receptor (fgfr2-3), essential for proliferation and
differentiation of osteoblasts69,70. Mice deficient in runx2 inhibited downstream atypical
expression of fgfr2-3, leading to abnormal proliferation of osteoblast progenitors in the
calvariae and mandibles69. The osteoblast performs various functions in osteogenic
repair, homeostasis of the bone matrix, and downstream differentiation, so ALP and
Runx2 execute proper communication pathways early in bone formation.
Osteoclasts are a second primary cell type within the bone matrix required for
health maintenance. The osteoclast primarily acts to resorb bone tissue that is damaged
or in the process of dying so that osteoblasts can lay down the additional mineralized
bone matrix. Several diseases are related to abnormal osteoclast activity, such as
osteoporosis, osteopetrosis, Paget’s disease, and rheumatoid arthritis71. Therefore, the
dynamic process of osteoclast and osteoblast activity needs to be finely balanced to
promote proper bone growth, especially in damaged tissue areas.
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The last primary cell type residing within bone is the osteocyte that comprises
90-95% of the total cell population within bone tissues14. The osteocyte forms many
extended constituents protruding from the cell body forming junctions with other
neighboring cells within the canaliculi. Osteocytes mainly act as sensory cells whenever
mechanical or chemical strains of the osteon are endured, acting as a feedback loop to
activate osteoblast and osteoclast activity.
A

B

Figure 2-3. A.) The basic features of osteoblast organization, an osteon. During bone
mineral transport, the process of mineral deposition produces acid. Exclusively during
mineral transport, osteoblasts also transport hydroxyapatite-binding fluorescent
molecules B.) A low-power view showing the continuity of bone-lining osteoblasts (white
arrows) and well-preserved marrow; dark regions are developing red blood cells72.

2.3 BMP Signaling pathway
The cascade of events that occur with the introduction of Bone Morphogenetic
Proteins (BMPs) in cellular development and subsequent metabolic pathways is
complex. However, this process must thoroughly be understood so future therapies can
be provided for gene therapy interventions and targeted molecular therapies are
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designed properly. BMPs allow for many essential biological processes to function like
bone formation, cell growth, and differentiation. For example, without BMP-2 or BMP44 protein complexes, the body would not thrive and maintain homeostasis. BMP-2 and
BMP-4 are two closely related members of the TGF-Beta superfamily73. The TGF-Beta
superfamily comprises many different proteins that exist within the body handling many
different bodily functions. Regulation of cell growth, proliferation, differentiation,
adhesion, migration, and apoptosis are all processes controlled by this superfamily of
proteins74. Other proteins in the TGF-Beta family include activins/inhibins, growth
differentiation factors, and Glial Derived Neurotrophic Factors75. All BMP molecules
share a distinct feature on the C-terminus end; this region contains seven cysteine
residues75. The BMP family can be further classified into subclasses. Subclass A includes
BMP-2 and BMP-4 due to the 80% homology seen between the two proteins. They are
also 92% identical on the carboxyl-terminal regions in regards to their amino acid
sequence 76.

Figure 2-4. Chemical structure of a BMP molecule before secretion out of the cell 76
The homology seen between BMP-2 and BMP-4 is something to note. This
indicates similar functions for each of these two proteins recognized as factors to induce
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differentiation. In the absence of BMP-4, BMP-2 can compensate for resolving the
cascade of events temporarily, and experiments performed with mice demonstrated
this situation as gastrulation of embryos does not usually occur in the absence of BMP4. Furthermore, BMP-2 overlaps BMP-4 localization sites in the heart, amnion, and
allantois due to the protein homology. This can help induce further development than
expected in embryos if BMP-4 is absent or dysfunctional76. BMP-2's involvement would
be anticipated to replace BMP-4 as the genetic sequence allows the system to
temporarily rely on BMP-2 until an adequate supply of BMP- 4 can be used once again,
as this was the case in experiments performed. BMP-4 was removed from an embryo in
vitro to see its effects on embryogenesis and the ability to maintain homeostasis. Most
embryos did not survive past one week, but some embryos did survive past this stage
when BMP-2 was overexpressed. In overexpressed cases, BMP-2 needed to be upregulated as BMP-2 would still need to perform the normal functions it associates with,
such as preserving functional characteristics of the amnion, gut, and heart77. The
developing embryos still ended in a fatality in the absence of BMP-4, though, suggesting
that BMP-2 cannot sustain all of the functions of BMP-4 long term.
The actual BMP signaling cascade starts with an initial precursor molecule inside
the cell's cytoplasm before secretion of the mature BMP molecule can occur. The preprotein consists of a signal peptide, propeptide domain, and a mature peptide sequence
on the carboxy-terminal (Figure 2-4)75. Once a signal generates a need for BMPs, the
signal peptide of the BMP is cleaved to start the secretion process. The BMP molecule
undergoes glycosylation and dimerization of the propeptide domain and mature peptide
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sequence. The propeptide domain is cleaved after the glycosylation and dimerization
but before secretion out of the cell. Thus, a conformational change occurs after
secretion to form the newly created BMP ready to be used by cellular mechanisms
throughout the body. The mature BMP is derived from the carboxy-terminal region as a
heterodimer or a homodimer 75.
Figure 2-5 represents the BMP pathway with a cell surface receptor that initiates
signaling transduction of transcription factors including NKX2-5, ATF-2, MEF2C, HAND2,
and MYOCD, along with the Smad complex within the cytoplasm.

Figure 2-5. Schematic of the mechanistic process of the signaling cascade for BMP and
its associated receptor73.
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BMPs first bind to cell surface receptors based on the BMP molecule, where a
signal complex initiates the process. BMP-2 and BMP-4 bind to type I (ALK3 and 6)
receptors, while BMP-6 and BMP7 bind to type II receptors (BMPR-2, ActR-2A, ActR-2B).
Moreover, when a BMP molecule binds to its particular receptor, the event signals a
close-by type I or type II receptor to be phosphorylated, creating a high-energy complex
of Smad proteins within the cytoplasm. Smad protein complex act as a signal transducer
within the cytoplasm to activate a transcriptional response within the nuceleus75.
Several Smad proteins exist in different locations throughout the body, forming unique
complexes dependent on the type of BMP bound to the cell's receptor. Generally, Smad1, Smad-5, and Smad-8 form heteromeric complexes with Smad-4 within these activated
complexes. Smad-6 and Smad-7 proteins act as inhibitors to the system if
overexpression occurs75. Other modulators such as Noggin exist outside the cell and
bind to the receptor without a BMP molecule. The BMP signaling cascade directly
impacts the differentiation process into osteogenic lineages and is essential for healthy
tissue formation in trauma-induced areas.

Chapter 3
DETERMINING EXPRESSION OF GHK AND MHNTS WITH HASCS

3.1 Introduction
While the capacity for the use of hASCs in tissue engineering shows promise, the
influence of GHK conjugated tripeptides on their proliferation and osteogenesis has not
been characterized with metalized halloysites. Nanomaterials have shown great promise
to influence a stem cell's capacity to grow and differentiate, so combining metalized
halloysites with tripeptides will increase our knowledge for wound healing applications.
In addition, developing enhanced therapies for the use of stem cells for regenerative
medicine can advance nanomaterial capabilities. This leads to a better understanding of
manipulating and using the cells for tissue engineering and other clinical purposes.
Glycyl-L-Histidyl-L-lysine (GHK), GHK-palmitic acid (GHKP) and GHK-stearic acid
(GHKS) were incorporated into stem cell cultures at the desired concentration of 50
micromolar to determine the impact on hASCs proliferation and gene expression
profiles. The nanoparticles were characterized through mass spectroscopy, purified by
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high-performance liquid chromatography, and further characterized with electron
dispersion spectroscopy (EDS) and scanning electron microscopy (SEM).
We hypothesized that hASCs would differentiate into a fibroblast morphology
after incorporating tripeptides and CuHNTs, and osteogenic potential will decrease after
CuHNTs and tripeptides are applied to cell-based cultures. SrHNTs will develop and
stimulate bone markers in gene expression due to strontium being a synergistic metal
ion for osteoclast activity. Exploring the role of GHK with metalized halloysites has
significant implications to stimulate pathways in hASCs for the formation of different
tissues. The qualitative and quantitative results will lead to a better understanding of
gene expression during the differentiation and proliferation process of hASCs.
The influence of biomaterials on stem cell fate will be evaluated using metalized
halloysites and metalized halloysite composites incorporated with GHK, GHKP, and
GHKS. GHK has a high affinity for copper in nature, and previous lab members have
demonstrated the ability to metalize halloysites with copper (CuHNTs). GHK, GHKP, and
GHKS were mixed at a 1:1 ratio with CuHNTs in dry powder and incubated overnight,
upon being placed in ultrapure water at 8°C before added to in vitro models with hASCs.
The experimental design was evaluated through particle confirmation-based assays
followed by live-dead and gene expression analysis.
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3.2 Materials & Methods
3.2.1

Particle Confirmation
3.2.1.1 Mass Spectrometry (MS)
Tripeptides GHK, GHKP, and GHKS were formed from solid-phase synthesis by

LifeTien LLC, confirmed through MS by LifeTien LLC, and shipped overnight
(Lifetien.com)
3.2.1.2 High performance Liquid Chromatography (HPLC)
Reverse phase HPLC purified the tripeptides and then were shipped by LifeTien
LLC overnight (Lifetien.com). The tripeptides were processed through a polar mobile
phase and a non-polar hydrophobic stationary phase. The non-polar phase utilizes
Carbon 18 molecules attached to a silica substrate. This allows a wide range of
molecules to be purified.
3.2.1.3 Scanning Electron Microscope (SEM)
The tripeptides were imaged with SEM to better visualize the particles at the
nanoscale and confirm the presence of attachment of the tripeptide to metalized
halloysites. 0.1 g of each nanoparticle was loaded onto a metal disc that was coated
with a carbon-polymer tape to anchor down the samples. Tripeptides were coated with
a 5-nanometer silver layer using a sputter prior to visualization to enhance contrast. The
samples were then loaded into the vacuum chamber for analysis. Measurements were
taken at x400, x8k, x40k, x80k, and x100k.
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3.2.1.4 Energy Dispersion Spectroscopy (EDS)
The mHNTs and tripeptides were analyzed with EDS to confirm the presence of
essential elements in the CuHNTs and tripeptides. 0.1 g of each nanoparticle was loaded
onto a metal disc that was coated with a carbon-polymer tape to anchor down the
samples. The samples were then loaded into the vacuum chamber for analysis.
3.2.2 Generation of nanocomposites
A non-sacrificial standard two-electrode electrolysis setup was assembled
consisting of two platinum-coated titanium mesh electrodes acting as a reversible
cathode and anode. The electrodes were gently cleaned using silicon carbide abrasive
papers and ultrasonicated in distilled water for 10 minutes to remove any surface
contamination. The electrodes were held parallel at a 2-inch distance and connected to
a DC power source (VWR Accupower 500 electrophoresis power supply).
An ultrasonicated colloidal solution of 700 mL of 5mM CuSO4 (Sargent-Welch
Cat. # WLC3649T) and 350 mg HNT (Aldrich Cat. #MKCF6902) were dispersed in the
electrolysis vessel (1000 mL VWR borosilicate glass beaker) and continuously stirred
using a magnetic stir bar to reduce electrophoretic buildup and precipitate formation at
the working electrode. A temperature of 85°C was maintained during the duration of
the electrolysis process. The 20V charge was applied in 5-minute intervals, after which
the polarity was reversed. This process continued for a total of six 5-minute cycles for a
total of 30 minutes.
The supernatant was decanted and washed with deionized water three times.
The solution was centrifuged at 2000 rpm for 5min with water to separate mHNTs from
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the unreacted NPs. The supernatant was removed. The unreacted NPs collect on top of
the dense pellet after centrifugation and were removed. The mHNTs were then dried at
37°C and stored overnight until combined with GHK, GHKP, or GHKS.
The influence of biomaterials on stem cell fate was evaluated with metalized
halloysite composites incorporated with GHK. GHK has a high affinity for copper in
nature, so GHK, GHKP, and GHKS were mixed at a 1:1 ratio with CuHNTs in dry powder
form, vortexed for 15 seconds, and incubated overnight. The particles were then added
to ultrapure water at 8°C. The particles were added to tissue culture plates ranging from
10-50 μM at physiological pH up to 28 days.
3.2.3 Cell Culture Media
400 mL of Dulbecco’s Modification Eagle’s Medium (DMEM) (R&D Cat.
#M22650) with 4.5 g/L glucose, L-glutamine, sodium pyruvate was combined with 47.5
mL of fetal bovine serum (FBS)(Neuromics Cat. #FBS002) and 5 mL of penicillin
streptomycin solution (Corning Cat. #25815001). The solution was then filtered with a
100-nm vacuum filtration system. The solution was labeled and placed into the
refrigerator for storage until ready to use.
3.2.4 Cell Culture Growth
ScienCell human adipose-derived stem cells (Cat. #7510) were used as a cell
source for this study. Cells were thawed from liquid nitrogen and grown on a 15 cm
tissue culture plate to expand the working cell population in an incubator a 37°C and 5%
CO2. After reaching 90% confluency, cells were passaged for further expansion and
experimental studies. First, media was removed, and 3 mL of 0.25% trypsinEDTA (R&D
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Cat. #B81210) was added for 3 minutes. The plate was gently tapped and shook to
detach remaining cells in the tissue culture plate. 7 mL of media was added to the plate
to suspend the cells throughout the media and dilute the trypsin. The cells were spun
down at 1500 rpms for 8 minutes and the trypsinEDTA/media solution was aspirated.
The cell pellet was resuspended in 10 mL of media upon the cells were being counted on
an automated cell counter (Cellometer).
3.2.5 Immunofluorescent Live/Dead Staining
The live nucleus was stained blue by using a fluorescent tag that binds to A-T rich
regions in the nuclear DNA, known as Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl1-piperazinyl]-2,5'-bi-1H-benzimidazole)(Cat. #A020A). Excitation and emission at
360/460 nanometers. Dead cells were probed with EasyProbes propidium iodide for red
at excitation and emission 535/620 or EasyProbes Green at 490/520 (Cat. #A020B). The
reading was performed on a Cytation 5 plate reader and cells were counted using the
plate reader and ImageJ software.
3.2.6 Gene Expression Analysis
3.2.6.1 RNA Extraction
Gene expression analysis was performed on samples for 1, 2, 3, 7, and 14 days.
RNA was extracted on 6cm tissue culture plates using 500 microliters Trizol (Invitrogen
Cat. #15596026). The cells were incubated for 5 minutes upon a cell scraper being using
to collect the tissue. The mixture was placed in an Eppendorf tube with 100 microliters
of chloroform (Aldrich Cat. #SHBG1013Vand inverted 15 times over two minutes. The
samples were then centrifuged at 15,000g for 15 minutes. The tube contents were
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separated into 3 distinct layers. The RNA was carefully extracted from the top,
transparent layer and avoided the thick mucus middle and bottom phenol layer. The
supernatant was added to an Eppendorf with 25 micrograms of glycogen (Roche Cat.
#34990920) and 100 microliters of 99% proponal (Cat. #SHBL3018). The supernatant
was centrifuged again at 12,000g for 10 minutes. The pellet was then located on the
hinge side of the Eppendorf tube and the solution aspirated. The pellet was
resuspended in 75% proponal and centrifuged at 7500g for 5 minutes. The solution was
again aspirated, leaving only the remaining pellet to air dry. After the pellet became
clear, 50 microliters of RNAse free water diluted the RNA for storage at -80°C.
3.2.6.2 RNA Quantification
The nanodrop plate of the Cytation 5 plate reader was used to quantify the
extracted RNA. Two microliters of water were first placed on the nanodrop to filter out
the nuclease-free water in which the RNA is suspended. After the machine was blanked,
two microliters of the RNA sample were added in duplicate, and the values were
averaged to give concentration levels. The reading provided values in nanograms per
microliter and a 260/280 reading for RNA purity levels. In general, a value between 2.02-1 is considered to be pure RNA.
3.2.6.3 cDNA Synthesis
The cDNA synthesis was carried out immediately following RNA quantification. In
total, 1 microgram of RNA was used to reverse transcribe the quantified RNA using a
cDNA synthesis kit (ABM Cat. #G452). Synthesis was carried out using a Quantstudio3.
The cDNA was stored overnight at -20°C.
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3.2.6.4 RT-qPCR
Gene expression analysis was performed using a QuantaStudio3 fluorescent 96
well imager. Primers were designed for gapdh, runx2, ki67, and osteopontin using the
primer blast function at https://www.ncbi.nlm.nih.gov/. Each well contained 4
microliters RNAse free water, 4 microliters of Sybergreen (BioRad Cat. #64356402), 0.5
forward primer, 0.5 reverse primer, and 1 microliter of cDNA. A total of 50 nanograms of
cDNA was used per reaction. A melt curve was also performed to indicate, if any,
inadequate primer sequences.
Table 3-1. Oligonucleotide primers used in RT-PCR analysis
Runt-related transcription factor (runx2)
GCGGTGCAAACTTTCTCCAG (forward)
TGCTTGCAGCCTTAAATGACTC (reverse)
Osteopontin (opn)
AAGCAGCTTTACAACAAATACCCA (forward)
GACTTACTTGGAAGGGTCTGTGG (reverse)
Marker of proliferation (ki67)
CTTTGGGTGCGACTTGACGA (forward)
ACAACTCTTCCACTGGGACG (reverse)
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
ACCACAGTCCATGCCATCAC (forward)
TCCACCACCCTGTTGCTGTA (reverse)
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3.2.7 Statistical Analysis
Statistical analysis was performed using the Microsoft Excel Analysis plugin and
online software sources at https://astatsa.com/OneWay_Anova_with_TukeyHSD/. All
experiments were done in triplicate and with one-way analysis of variance (ANOVA)
with p < 0.05 as the significance level for statistical analysis and all the results were
reported as mean ± standard error (p < 0.05, n=3), unless otherwise specified.

3.3 Results
3.3.1 Mass Spectrometry
Mass spectrometry evaluated particle size before being received from LifeTien
LLC. Parent Peaks at the far right of each spectrum indicate the molecular weight of
GHK, GHKP, and GHKS in Figures 3-1 to Figure 3-3. Results indicate confirmation of each
tripeptide formed. Purity levels, chemical formula, and theoretical values of each
tripeptide are listed in Table 3-2. All tripeptides were above 98% pure after analysis by
high performance liquid chromatography.

Figure 3-1. Mass spectrum of GHK. The parent peak to the far right (yellow star)
indicates particle formation at a molecular weight of 341 g/mol.
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Figure 3-2. Mass spectrum of GHK-Palmitic Acid. The parent peak to the far right (yellow
star) indicates particle formation of 607 g/mol.

Figure 3-3. Mass spectrum of GHK-Steric Acid. The parent peak to the far right (yellow
star) indicates particle formation at 579 g/mol.
Table 3-2. Purity levels of GHK, GHK-palmitic acid, and GHK-steric acid after HPLC.
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3.3.2 HPLC
After MS was performed, reverse-phase high performance liquid
chromatography (HPLC) was used to purify the tripeptides at levels greater than 98%,
also indicated in Table 3-2 (performed by LifeTien LLC). The spectrums in Figures 3-4 to
3-6 designate a steady baseline with large peaks in the projected area over time. The
area under the curve indicates the concentration of each tripeptide.

Figure 3-4. High performance liquid chromatography spectrum of GHK giving a 98.74%
purity level.

Figure 3-5. High performance liquid chromatography spectrum of GHK- palmitic acid
giving a 98.0% purity level.
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Figure 3-6. High performance liquid chromatography spectrum of GHK- Steric acid giving
a 99.45% purity level.
3.3.3 SEM and EDS
SEM provided a visual representation of each nanoparticle. While SEM can help
visualize particles at the micron and nano scales, analyzing biological molecules remains
challenging because of the high energy beams produced by the apparatus. Coating
biological molecules with thin layers of metal ions allows for better contrast to be
generated by SEM78,79. However, coatings often distort molecules, especially biological
molecules and amide bonds holding together amino acid sequences, as seen with GHK
in Figure 3-12. The architecture of GHK produced abnormal spiky formations after being
coated in silver with a 5-nanometer layer thick coating. GHKP and GHKS produced
blurred images when getting down to the nano-level (Figures 3-9 and 3-10) but
congregated flaky layers can be seen at the micron level for GHKS in Figure 3-7. The
CuHNTs were identified as cylindrical nanotubes as expected from previous work done
in the BioMorPH lab indicated in Figure 3-13, and when GHK was combined with
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CuHNTs (Figure 3-14), spherical fragments can be seen attached to the surface of the
CuHNTs indicating that GHK has reacted with the copper surface.
EDS confirmed essential elements of carbon, nitrogen, and oxygen within the
tripeptide formations in Table 3-3, and Figures 3-16 to 3-22 represent the spectral
analysis of each tripeptide, CuHNTs, and GHKCuHNTs. Figure 3-16 displays how the
polymer tape, used to anchor down the nanomaterials, is comprised of carbon and
oxygen. This is important to note because Figure 3-21 and 3-22 shows carbon and
oxygen displayed with the CuHNTs at high levels. Carbon and oxygen should not be
observed with the CuHNTs.

Figure 3-7. Scanning electron microscopy of GHK-Stearic acid at 400x and coated with
silver at 5 nanometer thickness. Congregated flaky layers can be seen throughout the
image.
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Figure 3-8. Scanning electron microscopy of GHKCuHNTs at 400x. The particles tend to
clump together through charged interactions.

Figure 3-9. Scanning electron microscopy of GHK-palmitic acid at x100k and coated with
silver at 5 nanometer thickness. The image contrast was still blurred after the coating
process but spherical masses can be seen.

40

Figure 3-10. Scanning electron microscopy of GHK-stearic acid at x110k and coated with
silver at 5 nanometer thickness. The image contrast was still blurred after the coating
process but spherical masses can be seen.

Figure 3-11. Scanning electron microscopy of GHK at x100k and coated with silver at 5
nanometer thickness. The images contrast was still blurred after the coating process but
spherical masses can be seen.
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Figure 3-12. Scanning electron microscopy of GHK at 8000x and coated with silver at 5
nanometer thickness. Spiky projections were visualized after the coating process,
suggesting GHK architecture was distorted.

Figure 3-13. Scanning electron microscopy of CuHNTs at x40k. Cylindrical nanoparticles
were visualized throughout the sample.
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Figure 3-14. Scanning electron microscopy of GHKCuHNTs at x80k. Cylindrical
nanoparticles are visualized and what appears to be GHK covalently attached (indicated
by arrow).

Figure 3-15. Scanning electron microscopy of GHKPCuHNTs at x80k. The blurred image
cannot confirm the attachment of GHKP with the CuHNTs.
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Figure 3-16. Electron dispersive X-ray spectroscopy confirming the presence of carbon
and oxygen used within polymer tape of the EDS system.

Figure 3-17. Electron dispersive X-ray spectroscopy confirming the presence of essential
elements for amine and carboxyl groups for GHK. Slight peaks for fluorine were
recorded.
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Figure 3-18. Electron dispersive X-ray spectroscopy confirming the presence of essential
elements for amine and carboxyl groups for GHKP. Slight peaks for chlorine were
recorded.

Figure 3-19. Electron dispersive X-ray spectroscopy confirming the presence of essential
elements for amine and carboxyl groups for GHKS. Slight peaks for fluorine were
recorded.
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Figure 3-20. Electron dispersive X-ray spectroscopy confirming the presence of essential
elements for amine and carboxyl groups along with copper and aluminosilicates in
GHK/CuHNTs.

Figure 3-21. Electron dispersive X-ray spectroscopy colored micrograph of CuHNTs.
Carbon and oxygen are picked up from the polymer-based tape used within the EDS
system.
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Figure 3-22. Electron dispersive X-ray spectroscopy confirming the presence of essential
elements in CuHNTs.
Table 3-3. Elemental analysis confriming the presence of Carbon, oxygen, and nitgrogen
within GHK, GHK-Palmitic acid, and GHK-Stearic acid. Mass percentages and atom
percentages are also given for each tripeptide. Larger amounts of Carbon are
anticipated for GHKP and GHKS due to the extended fatty acid of palmitic acid and
stearic acid conjugated to GHK, respectifully.
Tripeptide
Element
Atomic #
Mass %
Atom %
Carbon
6
42.69
49.63
GHK
Oxygen
8
24.63
21.49
Nitrogen
7
18.58
18.52

GHKP

Carbon
Oxygen
Nitrogen

6
8
7

65.67
18.25
16.02

67.11
14.02
14.06

GHKS

Carbon
Oxygen
Nitrogen

6
8
7

52.85
21.73
11.61

60.16
18.57
11.34
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3.3.4 Live/Dead Analysis
After characterization of each nanoparticle by EDS and SEM, a live/dead
fluorescent stain, in biological triplicates, was performed to ensure that hASCs remained
viable in culture after the nanomaterials were incorporated. Measurements were taken
in the same region of each tissue culture plate. Media was changed every 3 days with
the insertion of GHK, GHKP, or GHKS, along with combinations of SrHNTs or CuHNTs.
Control samples did not have incorporated tripeptides or metalized HNTs and were
grown in DMEM, 15% FBS, and 1% pen/strep only.
Cell viability-based assays with hASCs confirmed that 50 micromolar
concentrations over a 28-day growth period for incorporated metalized halloysites and
halloysites with tripeptides created ideal conditions for cellular growth and attachment.
In addition, cell viability remained above 90% for all samples after immunofluorescent
imaging and cell counting using a Cytation 5 cell imaging plate reader as indicated
in Figures 3-23 to 3-27. Phase contrast imaging in Figure 3-28 further confirms cellular
attachment of SrHNTs with hASCs as indicated by the arrows within the figure. Large
cellular clusters firmly attach around the SrHNTs with long filopodia also observed
throughout the phase contrast image, suggesting that the hASCs are migrating across
the culture plate.
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Figure 3-23. Immunofluorescent overlay images of GHK, GHK-P, GHK-S, and control
group after 7 days in culture. Live nuclei are stained blue. Dead cell debris is stained
green; n=3.

Figure 3-24. Immunofluorescent overlay images of GHK, GHK-P, GHK-S, and control
group after 14 days in culture. Live nuclei are stained blue. Dead cell debris is stained
green; n=3.
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Figure 3-25. Immunofluorescent overlay images of GHK, GHK-P, GHK-S, and control
group after 21 days in culture. Live nuclei are stained blue. Dead cell debris is stained
green; n=3.

Figure 3-26. Immunofluorescent overlay images of GHK, GHK-P, GHK-S, and control
group after 28 days in culture. Live nuclei are stained blue. Dead cell debris is stained
green; n=3.

Percent Viability
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Figure 3-27. Cell viability observed over the course of 28 days after nanomaterials were
incorporated at 50 micromolar concentrations; n=3. Images were taken from 3 separate
plates within the same region.

Figure 3-28. Phase contrast image of hASCs after 7 days in culture exposed to SrHNTs.
Cell have attached and are migrating across the culture surface (note the long filopodia,
red stars) clusters of cells (red arrows) were also observed.
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3.3.5 Gene Expression
The impact of GHK was quantitatively assessed through quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR). RNA was extracted using TRIzol,
followed by the synthesis of cDNA. Evaluation carried out by qRT-PCR assessed mRNA
expression from each sample collected, and gapdh served as the loading control to
ensure that mRNA concentration is consistent for each sample. Ki67 is a gene
specifically transcribed in proliferation only, giving us a good indication of increased or
decreased proliferation with SrHNTs, GHK, GHKP, GHKS, and CuHNTs incorporated with
each tripeptide. The marker runx2 is a transcription factor necessary early in bone
differentiation and was used to assess if the nanomaterials enhanced the process of
bone formation. Osteopontin is associated with osteoclast attachment to the
mineralized bone matrix, and this is a late-stage considered marker in bone cell
differentiation. Results for gene expression are displayed in Figures 3-29 to 3-41.

Figure 3-29. Increased expression of Ki67 after SrHNT Exposure for 7 days. Expression
was normalized to gapdh. P < .05*; n=3. Error bars represent ± standard error. NC
denotes the negative control.
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Figure 3-30. Increased expression of Ki67 and runx2 after SrHNT Exposure for 14 days.
Expression was normalized to gapdh. P < .05*; n=3. Error bars represent ± standard
error. NC denotes the negative control.

Figure 3-31. No significant difference in osteopontin were observed after SrHNT
exposure for 14 days. Expression was normalized to gapdh. P < .05*; n=3. Error bars
represent ± standard error. NC denotes the negative control.
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Figure 3-32. Increased expression of Ki67 after GHKCuHNT Exposure for 24 hours.
Expression was normalized to gapdh. P < .05*; n=3. Error bars represent ± standard
error. NC denotes the negative control.

Figure 3-33. There was no significant impact on runx2 after GHKCuHNT exposure for 24
hours. Expression was normalized to gapdh. P < .05*; n=3. Error bars represent ±
standard error. NC denotes the negative control.
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Figure 3-34. An increased expression of ki67 and decreased expression of runx2 was
observed after GHK exposure at 50 micromolar for 7 days. Expression was normalized to
gapdh. P < 0.05*; n=3. Error bars represent ± standard error. NC denotes the negative
control.

Figure 3-35. Increased expression of ki67 after GHK exposure at 50 micromolar was
observed for 14 days. P < 0.05*; n=3. Expression was normalized to gapdh. Error bars
represent ± standard error. NC denotes the negative control.

55

Figure 3-36. Increased expression of ki67 after GHK, GHKP, and GHKS exposure at 50
micromolar for 14 days. P < 0.05*; n=3. Expression was normalized to gapdh. Error bars
represent ± standard error. NC denotes the negative control.

Figure 3-37. A. decreased expression of runx2 was observed after GHK, GHKP, GHKS
exposure at 50 micromolar for 14 days. P < 0.05*; n=3. Expression was normalized to
gapdh. Error bars represent ± standard error. NC denotes the negative control.
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Figure 3-38. Decreased expression of runx2 after exposure to GHKS-CuHNT at 50
micromolar for 24 hours. P < 0.05*; n=3. Expression was normalized to gapdh. NC
denotes the negative control.

Figure 3-39. Increased expression of ki67 after exposure to GHKS-CuHNT at 50
micromolar. P < 0.05*; n=3. Expression was normalized to gapdh. NC denotes the
negative control.
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Figure 3-40. Increase in expression of ki67 after exposure to GHKP-CuHNT at 50
micromolar. P < 0.05*; n=3. Expression was normalized to gapdh. NC denotes the
negative control.

Figure 3-41. Increase in expression of ki67 after exposure to GHKP-CuHNT at 50
micromolar. P < 0.05*; n=3. Expression was normalized to gapdh. NC denotes the
negative control.
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3.4 Discussion and Conclusion
3.4.1

Particle Formation and Analysis
Mass spectroscopy (MS) first confirmed the different-sized peptide formations of

the tripeptides incorporated into cell-based studies. The parent peaks on the far right of
each MS spectrum confirmed the presence of the anticipated tripeptide. GHK was
identified at 341 g/mol, GHK-P at 579 g/mol, and GHK-S at 607 g/mol. This result aligns
with the theoretical values listed in Table 3-2. GHK was lipidized with steric acid and
palmitic acid, thus increasing the molecular weight and overall size of the conjugated
tripeptide. This result would yield a higher molecular weight as indicated by the mass
spectrum. Palmitic acid is a 16-carbon fatty acid while steric is slightly larger at 18
carbons. Particle formation indicated that the conjugated tripeptides aligned with
theoretical values as we would expect GHK-S to have the largest molecular weight.
The tripeptides were formed using 9-fluorenylmethyloxycarbonyl-chloride
(Fmoc) method in solid-state synthesis. Fmoc is used as a temporary protecting group of
the amino function in solid-phase synthesis of peptide chains, so side-chain derivatives
are not formed in the process. Fmoc is removed after a series of washes to extract
unbound amino acids before proceeding with synthesis. 2-Chlorotrityl chloride resin is
employed to synthesize the C-terminal end, and the carboxyl group of the amino acid
derivative attacks the methyl carbon. Chloride is the leaving group, which leads to the
linkage of Fmoc-amino acids to the 2-chlorotrityl chloride resin. Generally, peptide
synthesis used in the Fmoc process can lead to slight impurities with chlorine or fluorine
for GHK, GHKP, and GHKS, leading to the 98% purities levels established after analysis by
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EDS in Figures 3-17 to 3-1954. However, the peptides are added in solution to culture
media, and this dilutes the impurities significantly and does not cause adverse functions
of the formulated tripeptides.
High-performance liquid chromatography (HPLC) purified the peptide formations
once particles were confirmed by mass spectrometry. Purity levels greater than 98%
were achieved for GHK, GHK-P, and GHK-S as indicated in Table 3-2. EDS then confirmed
particle formations by identifying elemental analysis of carboxyl and amine groups
existing within the tripeptides. Given these considerations, it was suggested to move
forward with cell-based culture studies to analyze how the nanoparticles influence the
proliferation of hASCs and their capacity for tissue regeneration with in vitro models.
3.4.2 Live/Dead Staining
Following particle formation, a live-dead analysis confirmed the biocompatibility
of the tripeptides and mHNTs before moving forward with proliferation, gene
expression, and wound analysis assays. Cell culture studies with hASCs over 28 days
showed no significant cell viability changes as indicated in Figures 3-23 to 3-27 after cells
were counted on an automated cell counter. Cell viability percentages remained above
90% for SrHNT, GHK, GHKP, GHKS, and GHKCuHNTs over the course of 28 days.
Immunofluorescence then qualitatively confirmed the biocompatibility of the
nanoparticles over 28 days. The nucleus is stained using a fluorescent tag that binds to
A-T rich regions in the nuclear DNA, known as Hoechst 33342 trihydrochloride
Trihydrate, producing a deep blue. Acetoxymethyl ester is hydrolyzed by intracellular
esterase’s in the nucleus, confirmed the presence of live cells. A green or red dye
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(propidium iodide) binds with dead cell debris present in the culture dish and cannot
bypass intact cellular membranes.
3.4.3 Gene Expression
The application of SrHNTs had a significant increase in gene expression after 7
and 14 days for ki67 and an increase of runx2 after 14 days, while the late-stage marker
osteopontin produced no significant increase after 14 days. Expression of runx2 was
expected to increase during the 14-day time frame with the incorporation of SrHNTs
due to the prevalence of the ion in the bone formation process, and Figure 3-30
confirmed our hypothesis. Although an increase in ki67 represents proliferation taking
place with the hASCs, the bone marker, runx2, is also differentially expressed and an
early marker of bone differentiation, potentially activating downstream targets. The
hASCs are proliferating and differentiating after exposure to SrHNTs, as they would at
tissue-damaged sites if incorporated as bone implants. The bone formation process is
often slow, though, with healing taking several months based often the severity of the
injury and healing process through the inflammatory response, soft callus phase, hard
callus phase, and the remodeling process80. The late-stage bone marker osteopontin was
not significantly relevant as indicated in Figure 3-31, indicating that the hASCs are
experiencing early phases of bone differentiation.
Furthermore, the process of gene expression in cell-based cultures is still poorly
understood with the incorporation of nanoparticles, such as SrHNTs, that have yet to be
used for potential medical implants. However, there are clear indications that SrHNTs
can impact the bone formation process to speed recovery time in patients with
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diminished bone growth, non-unions, or prolonged areas of trauma. 3D printed bone
implants or calcium phosphates screws embedded with SrHNTs can play a role in bone
development, especially in patients with osteoporosis, osteomyelitis, or even geneticbased pathologies seen in Alagille syndrome brachydactyly and spondylocostal
dysostosis, and Hajdu Cheney syndrome81.
After assessing SrHNT effects in culture, gene expression analysis was performed
on the CuHNTs complex formed with each tripeptide. Gene expression showed a
reduction of ki67 after only 3 days in culture (Figures 3-38 to 3-41), indicating a change
from proliferation to differentiation into fibroblasts. The synergistic role of CuHNTs and
SrHNTs produced different outcomes in comparison to the tripeptides alone. Both ki67
and runx2 were decreased with GHKPCuHNTs and GHKSCuHNTs, suggesting
differentiation into a fibroblast morphology. However, other connective tissue pathways
could be activated, such as muscle or cartilage, and would need additional studies to
confirm.
Experiments incorporating GHK, GHKP, and GHKS indicated that hASCs were not
differentiating into the bone lineage but were accelerating the proliferation process
(Figure 3-36 to 3-37). After 14 days, GHK and GHKP exhibited over 15 times the normal
expression of ki67. This rapid expression profile indicates hASCs response to the
vascular endothelial growth factor pathway (VEGF). This primary response in tissue
formation is necessary to stimulate platelet activation, adhesion, and platelet plug
formation. The rise in ki67 promotes hASCs proliferation in open wound systems while
also promoting macrophages in adipose tissues82. Thus, the incorporation of GHK or
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GHKP, under the right conditions, can stimulate VEGF response and immune homing
capabilities.
The extended fatty acid chain on GHKP or GHKS can contribute to phospholipid
bilayer formation, receptor binding, and extend the half-life of GHK for the stimulation
of growth pathways in open wound systems. Additionally, stearic acid binding with fatty
acid binding protein E-(FABP)/retinoid acid receptor has already been shown to mediate
differentiation of CD11c+ macrophages in obese individuals83. Given that stearic acid
can bind to FABP, both palmitic acid and stearic acid can bind with this particular
receptor on hASCs or immune cells in tissue damaged sites to promote immune homing
of macrophages at tissue damaged sites.

3.5 Future Studies
The incorporation of tripeptides with metalized halloysites for tissue
regeneration needs additional studies using open wound systems. Gene expression
results indicated that GHK and the conjugated forms with fatty acids played a
fundamental role in manipulating how hASCs respond in an in vitro model. However,
widespread RNA-sequencing would be an ideal approach towards further understanding
the influence of GHK and mHNTs on differentiating hASCs into other cell lineages such
as myogenesis, chondrogenesis, and neurogenesis.
Protein expression analysis is a fundamental next step to build on gene
expression results. The analysis of Ki67 and Runx2 through western blot would confirm
direct protein management of GHK in hASCs. Once protein expression studies are
carried out, this will advance studies into animal models as this is necessary before
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moving to human-based studies. Prototypes bandages can be constructed using blowspun Polylactic acid (PLA) fibers with mHNTs and coated with tripeptides and/or fatty
acids for enhancing wound site recovery.
CuHNTs with GHK, GHKP, and GHKS, incorporated into blow-spun or electrospun
fibers, and applied to wound healing studies, would provide insight into their role in the
healing process. Electronspun or blow spinning methods will allow for equal distribution
of our newly formed nanocomposites throughout the fibers, increasing cellular
interactions. In addition, applying the nanoparticles to commercially available FDAapproved materials is an ideal application to enhance characteristics on proliferation
and biocompatibility. Several preliminary studies have been completed with metalized
HNTs, GHK, GHK conjugated to fatty acids, GHK bound with coppered halloysites, and
gene expression results indicate a desirable use of them for open wound systems.

CHAPTER 4
DETERMINING MIGRATORY PATTERNS AND ARTIFICIAL WOUND ANALYSIS

4.1 Introduction
The addition of previously mentioned nanoparticles was added to cultures of
hASCs to better understand the impact for wound healing applications. A scratch assay
and migratory pattern analysis were performed to quantify if any influence on cell
migration was enhanced. A p200 micropipette disrupted the cell monolayer for
imitation of artificial wound closure with associated scratch assays. After 24 hours in
culture, images were taken to analyze cell density and cell migration into the artificial
wound site by the wound closure plugin for ImageJ. The scratch assay's control did not
use nanomaterials or GHK derivatives, making it the baseline for comparison between
experimental groups. Environmental constraints often decide a stem cell’s fate, and the
proliferation of cells into the artificial wound site elucidates wound healing capabilities.
A cell invasion assay was used to identify cell migration patterns within a
transmembrane chamber. This assay consists of two chambers separated by a porous
membrane with cells seeded in the top chamber. In contrast, the bottom chamber
contains one of the previously mentioned nanomaterials acting as a chemoattractant.
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The cells were incubated in the top chamber and allowed to migrate through the
intervening porous membrane chamber at the bottom to assess the chemoattractant
characteristics of the nanomaterials. If more hASCs migrate from the top chamber
through the filter pores, we can be confident that the nanomaterials stimulate a homing
response. Detection of cell invasion is quantified using immunofluorescent staining
using Calcein AM solution. Cell dissociation/Calcein AM solution is placed in the bottom
chamber to dissociate the filter's migrating cells. Free Calcein fluoresced brightly and
was used to quantitate the number of cells passed through the transmembrane
chamber.
Nanomaterials often display antimicrobial properties, especially metals, because
of the oxidative states of ions in nature and their ability to penetrate the cell walls of
prokaryotes24,25. Studying how mHNTs or naturally occurring tripeptides secreted in
open wound systems is an important aspect to consider to enhance current wound
healing applications. Ideally, the tripeptides will not promote the bacterial growth of
gram-negative or gram-positive bacteria. We hypothesized that increased cell migration
would occur with exposure to the incorporated nanomaterials while also enhancing
antimicrobial attributes against S. aureus and E. coli.
The cell invasion and the scratch assay results will better indicate how hASCs
respond and proliferate to the external environment and whether they play a role in
homing capabilities. GHK is an ideal molecule to identify a potential role in advancing
wound healing and at what concentrations and combinations of other biocompatible
molecules influence cell migration.
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4.2 Materials and Methods
4.2.1 Immunofluorescent Live/Dead Staining
The live nucleus was stained blue by using a fluorescent tag that binds to A-T rich
regions in the nuclear DNA, known as Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl1-piperazinyl]-2,5'-bi-1H-benzimidazole)(Cat. #A020A). Excitation and emission at
360/460 nanometers. Dead cells were probed with EasyProbes propidium iodide for red
at excitation and emission 535/620 or EasyProbes Green at 490/520 (Cat. #A020B). The
reading was performed on a Cytation 5 plate reader and cells were counted using the
plate reader, and ImageJ software.
4.2.2 Alizarin Red Stain
After seeding, cells were stained with a 40 mM Alizarin Red S (ScienCell Cat.
#8678a) staining kit at an interval of 7, 14, 21, and 28 days. Cells were stained with
Alizarin Red S to determine if the cells were calcium-rich, indicating that the stem cells
differentiated towards an osteoblast lineage. A positive control was used for
comparison over the 28 day growth period (Gibco Cat. #A1007201). The pH of the
Alizarin Red was adjusted to 4.2 before use with the 10% ammonium hydroxide or 10%
acetic acid. Media was removed from each well, washed once, and cells were fixed with
500 μl of 10% formalin/per well for 20 minutes at room temperature in a 24-well plate.
The formalin was then removed, and each well was washed two times with 500 μl
distilled water. 500 μl of Alizarin Red S was added to each well and stained for 30
minutes at room temperature. The final step was to wash each well with water before
observing stained cells under an Olympus BX 41 Brightfield microscope.
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4.2.3 Scratch Assay
As previously described, cells were grown to 100% confluency on 6 cm tissue
culture plates in standard culture media. A fine tip marker was used to mark the bottom
of the plate to identify the regions before and after the scratch was performed. A
standard p200 pipette tip was used to gently scrape the cell monolayer leaving a distinct
zone for cells to proliferate and migrate towards. Images were then taken directly after
the scratch assay and 24 hours later to observe cell migration and proliferation patterns.
An ImageJ plugin, designed for scratch assay analysis, was used to quantitate cellular
response.
4.2.4 Proliferation Assay
A cell proliferation assay kit was used to asses cell growth over a 72-hour period
(Biosciences Cat. #A014). A 1X HBSS buffer (12.5 mL) was created by adding 2.5 mL of 5X
HBSS buffer with 10 mL of deionized water. 25 μL of Cell-Quant™ dye reagent was
added to 12.5 mL of 1X HBSS buffer. Cells were plated at 5000 cells per well in a 96-well
plate, combined with nanoparticles, and grown for 24, 48, and 72 hours. The growth
medium was removed from the cells by gentle aspiration, and 100 μL of 1X dye-binding
solution was adding to the 96 well plates. The microplate was incubated at 37°C for 30
minutes. Excitation and emission were read at 485/530.
4.2.5 Migratory assay
The migratory pattern assay (EMD Millipore Cat. #ECM515) identified the stem
cells' ability to migrate towards a chemoattractant through a filter with 8-micron pores.
In this case, the chemoattractant was our nanoparticles. Cells were placed at 5 X 10 3 in a
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96 well plate chamber plate. The chamber plate was then placed into a feeder tray with
serum-free media and the chemoattract. The cells were allowed to grow and migrate
through the pores for 24 hours and attach to the underside of the membrane. After 24
hours, the media solution in the top chamber was discarded. The chamber plate was
then placed in a warmed cell dissociation solution for 30 minutes at 37°C to detach the
cells that migrated through the pores and into the feeder tray. 75 microliters of the cell
solution were placed in a new 96 well plate along with 75 microliters of a lysis buffer
and green fluorescent dye. Excitation and emission were done at 480/520 on a Cytation
5 plate reader to measure fluorescent intensity.
4.2.6 Picrosirius Red Stain
Cells were grown for 14 and 28 day periods in a 12-well plate and stained for
collagen formation using Picrosirius Red (Diagnostic Biosystems Cat. #47248). Media
was removed, and the cells were washed with distilled water once. Cells were then fixed
in 10% formalin for 20 minutes and washed three times. Five hundred microliters of
Picrosirius red were added for one hour. Three additional washes with acetic acid
followed. Images were then taken with an Olympus BX41 brightfield microscopy. After
images were taken, the staining was quantified using ImageJ software for percent
coverage compared to the control group. Standard error was calculated, followed by a
one-way ANOVA and Tukey Post-hoc.
4.2.7 Antibacterial Testing
Bacterial cultures were prepared for testing bacterial growth inhibition after
exposure to a combination of tripeptides with CuHNTs. This assay will provide data on
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how tripeptide/CuHNT combinations might inhibit bacterial growth and their potential
for preventing biofilm formation. Muller-Hinton broth test tubes were used to provide
testing mediums for the antibacterial capabilities of the nanoparticles at 500
micromolar concentrations.
4.2.7.1 Muller-Hinton Broth
Liquid medium testing was facilitated using Mueller-Hinton broth (Aldrich Cat.
#BCBX5997). 5 mL of Muller-Hinton broth was added to each glass test tube and
autoclaved. Once the broth cooled overnight, samples were explicitly labeled for each
sample (CuHNT, GHK-CuHNT, GHKP-CuHNT, and GHK-CuHNT). E. coli and S. aureus were
used and presenting gram-negative and gram-positive bacteria. Glass culture tubes were
inoculated with 50 μL of E. coli or S. aureus after each nanoparticle was added to the
broth of each tube. Controls of uninoculated Muller-Hinton broth and inoculated broth
were used, along with a positive control using gentamicin. The cultures and controls
were incubated at 37°C for 48 hours before adding 5mL glass test tubes. Optical density
was calculated over time and up to 72 hours. Each test was done in triplicate, and the
results were averaged.

4.3 Results
4.3.1 Live/Dead SrHNTs
The fluorescent imaging of hASCs indicated large zones of cellular growth and
attachment around SrHNTs. A unique pattern over the 28 days formed trabecular-like
structures indicative of bone formation at contact sights of SrHNTs. The hASCs
compressed the SrHNTs into these patterns because the SrHNTs were initially dispersed
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in culture, and over time, they molded the patterns seen in Figures 4-2 to Figure 4-4.
Figure 4-1 demonstrates only 7 days in culture and a more dispersed pattern in culture.
The structures in Figure 4-4 can be seen from the naked eye due to the significant
growth of cells into cell clusters, and growth would likely continue if the experiment was
conducted past 28 days.

Figure 4-1. Left - 7 days after SrHNTs were added to hASCs at a 50 micromolar
concentration. Live cells stained in blue. Dead cells are in green. Note. That there was
some absorption of the dyes by the HNTs. 10x magnification. Right – cell clustering was
observed and apparent internalization of the SrHNTs (dark colored areas)(color
brightfield).

Figure 4-2. Left - Live dead stain 14 days after SrHNTs to hASCs were added at 50
micromolar concentration. 10x magnification for immunofluorescence and 4x bright
field microscopy images display. SrHNTs were starting to be compacted denoted by the
arrows. Live cells are stained in blue. Dead cells were stained green. Similar absorption
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of the dyes by HNTs was observed. Right – Cluster of cells and HNTs organized into a
‘trabecular like pattern (color brightfield).

Figure 4-3. left - Live dead stain 28 days after SrHNTs to hASCs were added at 50
micromolar concentration. 4x magnification for immunofluorescence and bright field
microscopy. Live cells stained in blue. Dead cells in green. Some absorption of dyes by
halloysite was observed. Clusters of SrHNTs can be seen and are denoted by arrows.
Right – Trabecular like structures are more apparent (color brightfield).

Figure 4-4. Cell migration was observed over time with SrHNTs with hASCs after 28 days.
The cell pattern manifested as trabecular-like structures (bottom left). Live cells are
shown in blue. Dead cells are shown in green. Cell structures can be seen by the naked
eye (top right)
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4.3.2 Alizarin Red Staining
Alizarin Red assessed the calcium deposits formed for the indication of early
bone differentiation processes. The experimental groups were compared to both a
negative and positive control group. The negative control group consisted of hASCs
gown in cell media with no nanoparticles incorporated. The positive control represented
a growth media optimized by Gibco for osteogenic differentiation of mesenchymal stem
cells. Calcium deposits were observed in the positive control group, along with SrHNTs
at a 50 micromolar concentration after 28 days. Groups using CuHNTs or tripeptides did
not exhibit any calcium deposits over the given time frame indicated in Figure 4-5.
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Figure 4-5. Alizarin Red staining of each well after days 7, 14, 21, and 28 days exposed to
GHKCuHNT, CuHNT, and SrHNT. A negative and positive control were used for
comparison. Calcium deposits were only observed in the positive control and SrHNT
groups.
4.3.3 Artificial Wound Closure
Artificial wound closure experiments were grown over a 24-hour time frame,
given the nature of the assay. Longer durations are not achievable in this setup due to
the doubling time of hASCs and the complete closure of the area for all groups.
However, the incorporated tripeptides of GHK, GHKP, and GHKCuHNT recorded an
increase in wound closure over 24 hours after quantitative analysis by ImageJ software.
A noticeable change is also observed qualitatively in Figure 4-6.
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Figure 4-6. Scratch assay of controls compared to GHK from time 0 hour to 24 hours. A
statistical analysis was carried out with a one-way ANOVA followed by Tukey post-hoc
analysis.
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Table 4-1. Wound closure area percentage after 24 hours. GHK, GHKP, and GHK-CuHNTs
showed a significant increase in wound closure percentage using the wound analysis
plugin for the ImageJ software.

4.3.4 Proliferation Assay
The proliferation assay provided additional support for wound closure
experiments measured by the fluorescent intensity of DNA binding complexes. Figure 47 reveals a significant rise in fluorescent intensities for the positive control, GHK, and
GHKP over 24 hours at 50 micromolar concentration. After 72 hours, only GHKP and the
positive control recorded a statistically significant result. Negative controls comprise no
nanoparticles while orange bars represent positive controls using a Gibco formulation to
promote proliferation of hASCs (Figure 4-7). Figure 4-8 displays a more comprehensive
range of 10-40 micromolar concentrations to assess if different concentrations impact
the proliferation process. Concentrations below 30 micromolar did not exhibit any
significant rise in proliferation over 72 hours.

Fluorescent Intensity
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Figure 4-7. Tripeptides incorporated at 50 micromolar concentrations. N=3 for all
samples; P < 0.05*; P < 0.01 **; statistical analysis was carried out using a one-way
ANOVA followed by Tukey post-hoc. Blue bars indicate negative controls with no
nanoparticles. Orange bars represent positive controls using a Gibco formulation to
promote proliferation of hASCs.

Figure 4-8. Proliferating hASCs over 24, 48, and 72 hours. 10, 20, 30, and 40 micromolar
concentrations were used for GHK, GHKP, and GHKS. Grey bars indicate negative controls
with no nanoparticles. Orange bars represent positive controls using a Gibco formulation
to promote proliferation of hASCs. N=3 for all samples; P < 0.05*; statistical analysis was
carried out with a one-way ANOVA followed by Tukey post-hoc.
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4.3.5 Migratory Pattern Assay
The migratory analysis of tripeptides and conjugated nanomaterials are
characterized in Figure 4-9. GHK was the only chemoattractant showing a rise in cell
migration through the chamber pores. A decrease in migration was observed for GHKP,
GHKS, GHKPCuHNTs, and GHKSCuHNTs.

Figure 4-9. Migratory assay measured after 24 hours. Nanoparticles were tested as a
chemoattractant for cell migration through an 8-micron sized pored chamber. N=3 for all
samples; P < 0.05*; P < 0.01 **; statistical analysis was carried out with a one-way
ANOVA followed by Tukey post-hoc. Fluorescent intensity at 580, emission at 620.
4.3.6 Picrosirius Red Staining
The Picrosirius Red stain produced bright red bands for all experimental groups
of GHK, GHKP, GHKS, and GHKCuHNTs. Controls produced a low amount of collagen
production and staining over the 28-day growth period in the tissue culture plates. The
images were additionally quantified with ImageJ software for percent coverage of the
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red-stained areas in Figure 4-11. The quantified results indicated a significant increase in
the percent coverage of all experimental groups.

Figure 4-10. Picrosirius red stain of hASCs microencapsulated at 8.0 x 108 and grown
over 28 days. Cell clusters formed and large deposits of collagen were distributed
throughout the culture plates. Collagen fibers are stained in red. Control groups
represented tissue culture plates that did not have nanoparticles incorporated.
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Figure 4-11. Percent coverage of Picrosirius Red stain analyzed by ImageJ software. N=3
for all samples; P < 0.01 **; statistical analysis was carried out with a one-way ANOVA
followed by Tukey post-hoc. Error bars represent ± standard error.
4.3.7 Antibacterial Testing
Antimicrobial properties were assessed using gram-positive and negative
bacteria. The bacterial growth was quantified for absorbance at 630 nanometers. After
72 hours, the control group became saturated, so the experiment concluded at this time
point. A decrease in growth is shown at 48 and 72 hours for E. coli and S. Aureus for
each nanocomposite indicated in Figures 4-12 and 4-13.
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Figure 4-12 CuHNTs and tripeptides incorporated at 500 micromolar in Mueller-Hinton
broth for 72 hours with S. aureus. Optical density readings were taken at 0, 24, 48, and
72 hours. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. (n=3)

Figure 4-13. CuHNTs and tripeptides incorporated at 500 micromolar in Mueller-Hinton
broth for 72 hours with E. coli. Optical density readings were taken at 0, 24, 48, and 72
hours. Optical density was taken at 630nm wavelength. Error bars represent ± standard
deviation. (n=3)
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4.4 Discussion and Conclusion
4.4.1 Live/Dead Assay
SrHNTs grown over 28 days displayed a trabecular-like bone formation in culture
indicated in Figures 4-2 to 4-4. The SrHNTs were dispersed evenly in culture initially,
only to be tightly compacted and formed a unique network for the cells to attach and
proliferate. The qualitative indication of cell migration patterns packed together
supports the hypothesis for the ability of SrHNTs to enhance osteogenic lineages and
the previous finding of increased gene expression of runx2 after 14 days.
4.4.2 Alizarin Red Staining
The Alizarin Red stained cells for calcium deposits grown in a 24-well plate over
28 days, including control cells. No calcium deposits were observed in negative control
samples containing only hASCs and culture media. Slight staining of calcium was
observed in the positive control optimized for bone differentiation in 7-day samples and
steadily increased over the growth period. Direct exposure of SrHNTs showed staining of
calcium around the SrHNT clusters, suggesting differentiation of hASCs into a
preosteoblast lineage in these given areas that directly contact the nanoparticles.
Tripeptides and/or CuHNTs did not exhibit any calcium deposits designated by no
observable calcium deposits in red. Research suggests that differentiation into the
lineage of osteocytes typically shows calcium deposits after 28 days or longer. The
formation of bone is typically a more protracted process than other tissue types due to
the dense nature of the material. However, our hypothesis supports the use of
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exploiting SrHNTs for bone induction capabilities, while indicating CuHNTs are better
suited for fibroblast formation after no calcium deposits were observed.
4.4.3 Scratch Assay
After cells were grown to 100% confluency, a p200 tip created an artificial
wound across the monolayer surface. The damaged layer across the medial line of the
plate represents a similar cellular response at tissue-damaged sites. The disrupted
cellular network responded to the external environmental pressures acting on them as
they would in the body. Over 24 hours, the artificial open wound system accelerated
growth was observed and quantitively assessed with ImageJ software for wound closure
percentage. The wound closure percentage was calculated by taking the total area at
time zero, subtracting the change in the area after 24 hours, and then dividing the initial
area multiplied by 100 to give the final values displayed in Table 4-1. The addition of
GHK, GHKP, and GHK-CuHNTs supported the hypothesis by significantly decreasing
wound closure over the 24-hour time frame.
4.4.4 Proliferation Assay
Cell proliferation was analyzed over 72 hours using a fluorescent protein that
binds directly to the DNA as the cells go through cell division processes. Figures 47 and 4-8 display that tripeptide concentrations influence the accelerated growth in the
first 72 hours of exposure. Concentrations between 10-50 micromolar were used with a
steady incline in proliferation as concentrations increased over time. 50 micromolar
concentrations were an ideal mark to use based on live-dead staining and other assays
previously performed. Adjusting tripeptide concentrations in culture is still a necessary
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component of future studies to optimize cell growth for open wound systems and
stimulate growth factor response systems. However, the assay findings supported the
hypothesis that tripeptides stimulate hASCs proliferation for potential wound healing
capabilities.
4.4.5 Cell Migration Pattern Assay
The migratory assay identified GHK as a natural chemoattract with hASCs over 24
hours. This was an expected outcome of the procedure due to the synergistic activities
known for GHK at tissue damage sites. To our knowledge, this is the first report of GHK
acting as chemoattract for hASCs in vitro. GHK readily dissolves in solution, allowing the
hASCs to respond as if an injury occurs through the transmembrane domain. The
lipidized GHK molecules did not produce the same desirable effects, though. However,
GHKP and GHKS are only partially soluble in solution due to the fatty acid chain, so GHKP
and GHKS molecules tend to sink in solution over time and thus cannot interact with the
cell monolayer of the transmembrane domain. This observation is an inherent flaw of
the migratory assay if the molecules in use are not completely dissolvable in a particular
solution used. In this case, serum-free media was used, so we know that the hASCs are
not responding to anything else in the media. We exhibited the same problems with
SrHNTs and CuHNTs particles. They are not soluble in water either and will rest at the
bottom of the underlying chamber, and no cellular interactions can occur.
4.4.6 Picrosirius Red
Collagen formation is crucial for any wound closure to properly heal over time
during maturation and remodeling phases. Collagen is the most abundant protein in the
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body and exists in virtually all extracellular matrixes. Picrosirius red is a robust, anionic
dye that can associate along cationic collagen fibers to enhance their natural detection
under light84. The insertion of GHK, GHKP, GHKS, and GHKCuHNTs produced vibrant red
bands in culture over a 28-day growth period. The controls produced light staining,
indicating a low rate of collagen or fibroblast formation. The images were additionally
evaluated for percent coverage using ImageJ software for quantitative analysis.
Incorporation of each nanomaterial indicated a significant coverage area of collagen
production, as indicated in Figure 4-11 compared to control groups. This result supports
our hypothesis because the introduction of tripeptides and GHKCuHNTs produced large
amounts of collagen over time, promoting the differentiation of hASCs into fibroblasts
based on qualitative and quantitative data analysis.
4.4.7 Antibacterial Testing
The assessment of antimicrobial capabilities for the nanocomposites was
evaluated by both E. coli and S. aureus, gram-negative and gram-positive, respectively.
The bacterial growth in the control group leveled off after 72 hours, indicating the broth
had become completely saturated. The assay indicated a decrease in bacterial growth
over the 72-hour time frame using a 500 micromolar concentration for each
nanomaterial indicated in Figures 4-12 and 4-13. However, the level of growth
compared to the positive control group, using a gentamycin tablet, exhibited far better
antibacterial resistance. However, the broth was much clearer near the bottom of the
test tube where the nanocomposites resided. The nanocomposites remained insoluble
in broth, and the bacteria may have grown above this area to maintain some bacterial
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growth. Different concentrations of nanocomposites could be explored to gain a more
desirable impact with the nanocomposites, however. There were no significant
differences between CuHNTs, GHKCuHNTs, GHKPCuHNTs, and GHKSCuHNTs in bacterial
resistance for E. coli and S. aureus. It is important to note that there was no increase in
antimicrobial activity after incorporating each nanomaterial, leading to their use in a
bandage for wound healing and infection protection.

4.5 Future Studies
To expand on artificial wound analysis and migratory patterns, an in vivo animal
model involving male Sprague-Dawley rats would be a better system to evaluate the
effectiveness of metalized halloysites and GHK bound halloysites for regenerative tissue
applications. Rats provide an ideal mammal model to expand in vitro capabilities due to
the relative low cost compared to larger mammals (rabbits, monkeys, etc.), adequate
dorsal area for wound creation, and similar wound healing mechanisms seen in humans.
The use of metalized halloysites has already shown their cytocompatibility and
antimicrobial attributes in human cell culture experiments, so testing our hypothesis
and technology with male Sprague-Dawley rats to evaluate the efficacy of GHK bound
halloysites is the natural next step. GHK is a naturally occurring biological molecule
known to aid in angiogenesis, prevent pain/inflammation, and possess anti-cancer
properties. GHK is an ideal molecule to combine with our metalized and drug-doped
halloysite to regenerate tissue faster, eliminate infection, and prevent
pain/inflammation. Diabetic and ischemic wound patients, amputees, and lifethreatening burn/trauma victims can all benefit from our patented and multifunctional
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bandage technology. Assessing host immune response during the complexities of
wound healing in rats is a necessary step to evaluate the effectiveness of GHK bound
halloysites for regenerative medicine.
Halloysites would first be coated with metal ions and mixed in solution to bind
GHK, GHK-Palmitic acid, or GHK-Steric acid. Electro-spun or blow-spun PLA bandages
coated with our Halloysites nanoparticles would then be assembled. Once the bandage
is constructed, 5 groups of rats would be used, with 6 in each group at a statistical
power of 90% and 0.8 effect size based on GPower calculations. The four experimental
groups would be compared with a control group using traditional gauze and antibiotics.
An additional 10% attrition rate is also generally applied in animal studies for a total of
33 rats to be used for the experimental design.

Figure 4-14. GPower calculations based off a one-way ANOVA for ethical use of
nanoparticles combined into FDA approved materials.

CHAPTER 5
INVESTIGATING 3D MATRIX FOR TISSUE FORMATION

5.1 Introduction
Alginate-based biomaterials have widely been applied to repair both soft and
hard tissues, including skin and bone, partly because alginate is a naturally occurring,
cost-effective alternative derived from brown algae known as Sargassum
angustifolium85,86. Similarly, injectable-based alginate systems, using Akermanite, a
bioceramic composed of magnesium instead of aluminum found in halloysites,
facilitated wound closure over 21 days in mice87. Given these considerations, hydrogels
were chemically crosslinked with 4% w/v sodium alginate with calcium chloride and
embedded with CuHNTs for in vitro models.
Alginate hydrogel microspheres were also used to encapsulate hASCs and
exposed to GHK based nanoparticles previously described. Reverse crosslinking occurs
when the sodium ions get replaced by calcium ions forming a gel polymer of calcium
alginate. GHK, GHK-P, GHK-S, and GHK-CuHNTs were added to the 4% sodium alginate
solution before crosslinking. Controls with no tripeptides or metalized HNTs were used
for comparative analysis. Cells were encapsulated by mixing a trypsinized cell
suspension in DMEM at a density of 8X105 cells per mL in the alginate solution. Dropwise
87
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microspheres were added to a 75 micromolar concentrated calcium solution for 15
minutes before being added to culture plates and stored at 37°C and 5% CO2. Picrosirius
Red stain was used to stain extracellular matrix proteins, and the stained hydrogels
were imaged under a light microscope, SEM, and immunofluorescent staining.
Alginate microspheres provide an ideal 3D environment to address the physical
pressures to which cells respond and increase their ability to stimulate the desired cell
response. We hypothesized that introducing GHK nanocomposites into the alginate
microspheres would increase cell proliferation and differentiation by providing
enhanced cellular support for the activation of wound healing pathways, such as VEGF.
This pilot study should enhance our understanding of how GHK nanocomposites and
hASCs may be used in either hydrogel applications or 3D bioprinting for tissue
regeneration.

5.2 Materials and Methods
5.2.1 Cell Microencapsulation
Human ASCs were trypsinized, suspended in media, and spun down at 1500
rpms for 8 minutes before encapsulation. Cells were then transferred to medical-grade
sodium alginate (Aldrich Cat. #SHBL1627) dissolved in PBS at a concentration of 40
mg/ml at a concentration of 8 × 10 5 cells/ml and cross-linked in a calcium solution
containing glucose and HEPES. Calcium cross-linking solution: 75 mM CaCl2, (Fisher Cat.
#AD5053) 90 mM glucose, sodium pyruvate, and 10 mM HEPES in ultrapure water; pH
was 7.3. After combining equal volumes of the cell suspension and 4 % alginate (w/v),
the alginate–cell suspension is transferred to a sterile syringe. The syringe is equipped
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with an inner diameter of 0.175 mm. Alginate microbeads were allowed to cross-link for
15 minutes. After washing with PBS to remove the excess calcium ions, the microbeads
were suspended in cell culture media containing DMEM, 15% FBS, and 1% pen/strep.
5.2.2 4K high resolution digital Imaging
Imaging of the hydrogels took place on a VHX 700 digital microscope (Keyence)
at 2500x to visualize pores and cross-linking of the hydrogels. The VHK system combines
a 4K CMOS image sensor and illumination technique to rival SEM imaging at micron
levels.
5.2.3 Immunofluorescent live/dead staining
The live nucleus was stained blue by using a fluorescent tag that binds to A-T rich
regions in the nuclear DNA, known as Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl1-piperazinyl]-2,5'-bi-1H-benzimidazole). Excitation and emission at 360/460
nanometers. Dead cells were probed with EasyProbes propidium iodide for red at
excitation and emission 535/620 or EasyProbes Green at 490/520. The reading was
performed on a Cytation 5 plate reader.
5.2.4 Picrosirius Red staining
Cells were grown for 7, 14, 21, and 28 day periods to test for collagen formation
by picrosirius red staining. Media was removed and the cells were washed with distilled
water once. Cells were then fixed in 10% formalin for 20 minutes and washed three
times. 500 microliters of Picrosirius Red was added for one hour. Three additional
washes with acetic acid followed. Images were taken with colored brightfield
microscopy. After images were taken, the staining was quantified using ImageJ software
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for percent coverage compared to the control group. Standard error was calculated
followed by a one-way ANOVA and Tukey Post-hoc.

5.3 Results
5.3.1 Hydrogel Characterization
The hydrogels were created using sodium alginate and calcium chloride
hydrogels. Figures 5-1 and 5-2 display the hydrogel crosslinks as well as the micropores
created in the hydrogel system for nutrient migration into the porous gels. Figure 5-3
displays the topography of the gel to further characterize the crosslinking of the gel on
the surface and how valleys or peaks interact with the surroundings for nutrient
absorption. The pink hue of the gel is a result of media absorbed into the gel.
Characterizing the hydrogels provides evidence of the 3D matrix formed to support the
growth of encapsulated hASCs.
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A

B

C

Figure 5-1. (A) color brightfield of hydrogels approximately five millimeters in size at 20x
after 24 hours. Pink color in part due to absorbed media. (B) 100x magnification of
hydrogel (C) 500x magnification displaying crosslinking connections within hydrogel
construct.
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Figure 5-2. 2500X magnification displaying pores and crosslinking. The arrow indicates
micropores. A 7000 VHX Keyence digital microscope was used to focus on the
micropores and crosslinking of alginate and calcium.

Figure 5-3. Topography of hydrogels displaying valleys and peaks. 3D images were zstacked using a 7000 VHX Keyence digital microscope. The color bar indicates the
uneven surface and the presence of crosslinking over the surface.

93

5.3.2 Live/Dead Assay
The microencapsulated hydrogel provided a 3D environment for cellular growth
and possible differentiation. Clusters can be visualized by a bright blue fluorescent
image that stained the nuclei, much like tissue culture plate experiments, from readings
performed on a Cytation 5 plate reader at 10x magnification in Figures 5-4 to 5-7. The
embedded hASCs were difficult to focus on throughout the hydrogel because the cell
clusters were randomly distributed in the 3D network at varying depths. However, the
pilot study provided additional evidence of the novel nanoparticles GHKCuHNT formed
to be used in future studies to understand alginate hydrogels' capabilities for
encapsulating hASCs and how they respond to different biomaterials.
Day 7 – microencapsulation of hASCs in 4% alginate hydrogels
Negative control live stain

Negative control dead stain
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GHK 50 micromolar live stain

GHK-P 50 micromolar live stain

GHK-S 50 micromolar live stain

GHK 50 micromolar dead stain

GHK-P 50 micromolar dead stain

GHK-S 50 micromolar dead stain
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GHKCuHNT 50 micromolar live stain

GHKCuHNT 50 micromolar dead stain

Figure 5-4. Live dead Stain of microencapsulated hASCs over the course of 7 days. Live
cells are stained blue. Dead cells are stained orange/red. Large cell clusters formed
within the hydrogel system with no compromise in cell viability. The reading was
performed on a Cytation 5 plate reader.
Day 14 – microencapsulation of hASCs in 4% alginate hydrogels
Negative Control live stain

Negative control dead stain
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GHK 50 micromolar live stain

GHK 50 micromolar dead stain

GHK-P 50 micromolar live stain

GHK-P 50 micromolar dead stain

GHK-S 50 micromolar live stain

GHK-S 50 micromolar dead stain
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GHKCuHNT 50 micromolar live stain

GHKCuHNT 50 micromolar dead stain

Figure 5-5. Live dead Stain of microencapsulated hASCs over the course of 14 days. Live
cells are stained blue. Dead cells are stained orange/red. Large cell clusters formed
within the hydrogel system with no compromise in cell viability. The reading was
performed on a Cytation 5 plate reader.
Day 21 – microencapsulation of hASCs in 4% alginate hydrogels
Negative Control live stain

Negative Control dead stain
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GHK 50 micromolar live stain

GHKP 50 micromolar live stain

GHKS 50 micromolar live stain

GHK 50 micromolar dead stain

GHKP 50 micromolar dead stain

GHKS 50 micromolar dead stain
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GHKCuHNT 50 micromolar live stain

GHKCuHNT 50 micromolar dead stain

Figure 5-6. Live dead Stain of microencapsulated hASCs over the course of 21 days. Live
cells are stained blue. Dead cells are stained orange/red. Large cell clusters formed
within the hydrogel system with no compromise in cell viability. The reading was
performed on a Cytation 5 plate reader.
Day 28 – microencapsulation of hASCs in 4% alginate hydrogels
Negative Control live stain

Negative Control dead stain
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GHK 50 micromolar live stain

GHK 50 micromolar dead stain

GHKP 50 micromolar live stain

GHKP 50 micromolar dead stain

GHKS 50 micromolar live stain

GHKS 50 micromolar dead stain
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GHKCuHNT 50 micromolar live stain

GHKCuHNT 50 micromolar dead stain

Figure 5-7. Live dead Stain of microencapsulated hASCs over the course of 28 days. Live
cells are stained blue. Dead cells are stained orange/red. Large cell clusters formed
within the hydrogel system with no compromise in cell viability. The reading was
performed on a Cytation 5 plate reader
5.3.3

Picrosirius Red Staining
Picrosirius Red stain was used to identify possible collagen deposits existing

within the alginate hydrogels. The first 7 days of the staining procedure did not show
any collagen deposits for the control group. Furthermore, after 14 days, the alginate
microenvironment provided cellular support for the formation of collagen deposits in
the control groups. However, the incorporation of the tripeptides sped the collagen
formation process after 7 days as displayed in deep red staining displayed in Figure 5-8.
The collagen deposits were later quantified for percent coverage as displayed in Figure
5-9, and the results indicated a significant rise in staining and collagen deposits over 28
days compared to control groups. The encapsulated hASCs provided further evidence of
fibroblast morphology and how the insertion of nanomaterials can speed up this
process.
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Day 14

Day 21

Day 28

GHKCuHNT 50 μM

GHK-S 50 μM

GHK-P 50 μM

GHK 50 μM

Negative Control

Day 7

Figure 5-8. Picrosirius red stain of hASCs microencapsulated at 8.0 x 108 and grown over
28 days. Cell clusters are formed and large deposits of collagen are distributed
throughout the hydrogels and are stained in red. Photos were taken on an Olympus IX51
at 20x magnification.
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Figure 5-9. Percent coverage of Picrosirius Red stain analyzed by ImageJ software. N=3
for all samples; P < 0.05*; P < 0.01 **; statistical analysis was carried out with a one-way
ANOVA followed by Tukey post-hoc. NC denotes the negative control.

5.4 Discussion and Conclusion
5.4.1 4K high resolution digital Imaging
The topography was analyzed with a 7000 VHX Keyence digital microscope
displaying valleys and peaks over the surface of the hydrogels and indicated micropores
and channels created throughout the hydrogel matrix (Figure 5-1 to 5-3). The integrity
of the gels was well maintained over the 28 days, with no noticeable breakdown of the
gel in cell culture media during this time frame. Gels were created approximately 5 mm
in diameter shown in Figure 5-1(A). The crosslinking of alginate and calcium was also
distinctly displayed in Figure 5-2 to further confirm hydrogel formation.
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5.4.2 Live/Dead
The hydrogels used in this pilot study were created using natural polymer
alginate over 28 days that demonstrated significant cell microencapsulation potential
with hASCs and novel incorporated nanoparticles. Live/dead analysis indicated large cell
clusters forming within the gel constructs painted by the bright blue fluorescent staining
and minimal cell death shown in red/orange. The clusters can partly maintain their
integrity from micropores created through the crosslinking channels of calcium chloride
and sodium alginate seen in Figures 5.1 and 5.2. The hASCs were able to expand within
the hydrogels and limited to clusters given the nature of microencapsulation
environments, but this did not inhibit cell viability over time.
5.4.3 Picrosirius Red Staining
Staining for type 1 collagen production was accomplished through Picrosirius red
and built upon the initial tissue culture plate studies. As in the culture plate studies, the
control group exhibited minor staining, and the stain was again quantitatively confirmed
through ImageJ analysis by percent coverage of the area. The displayed clusters within
the microencapsulated environment showed large amounts of type 1 collagen
formation with the incorporated tripeptides and GHKCuHNT nanocomposite. The large
collagen formation indicated the differentiation of the hASCs used into a fibroblast
morphology from the large red stained clusters accompanied by the live/dead staining.
The GHKCuHNTs produced the most significant collagen production based on the
calculated percent coverage over 28 days. The alginate hydrogels and incorporated
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nanomaterials supported our hypothesis for collagen formation and differentiation of
hASCs into a fibroblast morphology.

5.5 Future Studies
Suppose we can discover the role of external cues dictating molecular activities.
In that case, hASCs combined into alginate hydrogels remain an ideal candidate for
degenerative bone conditions or areas of extreme trauma. For instance, osteoporosis
affects postmenopausal women where bones weaken significantly over time. This
process gives rise to different breaks, fractures, and complications due to infection
experienced at an older age. Encapsulated hASCs can be utilized and implanted in
patients to stimulate the formation of new, healthy bone tissue or vascularization. The
pilot studies encompassing the GHKCuHNTs are an ideal source to combine with tissuedamaged areas to produce healthy collagen tissues. There are also growth factors
secreted by hASCs, like FGF-2 and VEGF, that stimulate angiogenesis and directly relate
to tissue formation around the body. Exploring growth factor secretion profiles of
exosomes would be ideal in future studies to demonstrate how cells are attempting to
communicate with each other in these microencapsulated environments. FGF-2 and
VEGF secreted factors direct stem cell movement, acting as signaling molecules for
immune cells in wound healing, so considering these factors existing in the extracellular
matrix is essential to note in future studies. Understanding how the environment
impacts hASCs and their ability to aid tissue repair will alleviate bone-related
pathologies or advanced trauma areas and so needs further study.
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The use of hASCs, in combination with bioactive nanoparticles, provides an ideal
platform for future clinical studies involving wound care treatment of all varieties.
Development of nano-based carriers using GHK, combined with metalized halloysites,
will aid in cell attachment, growth secretion profiles, and antimicrobial properties. With
this knowledge, we can apply GHKCuHNT particles in FDA-approved materials for nanoenhanced bandages, especially those suffering from severe burns. Severe pain, sepsis,
scarring, and death are often associated with widespread burns, and the typical
treatment regimens for the larger area come from donor meshed split-thickness skin
grafts58. However, donor grafts or patient-derived grafts are not ideal when potentially
better options do not require grafting. Applying large-scaled hydrogels with
encapsulated hASCs to cover burn wounds would provide many immediate advantages.
The gels would act as a protective layer from the outside environment while lubricating
the area. Applying coatings over the hydrogels or embed GHK or mHNTs with hASCs
would stimulate proliferation and secretion profiles of vital growth factors for
accelerating skin repair. Think of the gel as a temporary skin that can effortlessly be
removed, allowing for the underlying tissue growth to be assessed on demand.
Like many other cells, hASCs respond to their physical and chemical
environment, so adding bioactive molecules improves the wound healing process. At
the same time, metal ions protect against infection by disrupting pathogenic
membranes. There are many other small molecules, like GHK, that need exploration to
increase how we treat trauma sites, burn victims, and eliminate infections outside of the
clinic. Tripeptides are vital components of the extracellular tissue formation process that
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enhance recovery sites and act as chemoattractants for immune cells. Therefore,
creating advanced tissue mimicking platforms is an ideal approach for wound care.
Identifying alternative healing methods is of ongoing interest in regenerative medicine,
and discovering a biomaterial’s influence has enormous potential to treat many
different pathologies in future clinical studies.
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